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1  German abstract (Deutsche Zusammenfassung) 
 
 
Hintergrund: Zur klinischen Anwendung der Internationalen Klassifikation von 
Funktionsfähigkeit, Behinderung und Gesundheit (ICF) wurde das 
„Umfassende ICF Core Set für Diabetes mellitus (DM)“ entwickelt. Es 
repräsentiert das typische Spektrum von Funktionsproblemen bei Patienten 
mit Diabetes mellitus.  
Ziel: Die Validierung des umfassenden ICF Core Set für Diabetes mellitus 
(DM) aus der Perspektive von Ärzten war Ziel dieser Studie. 
Methoden: Es wurden erfahrene Ärzte zu Problemen, Ressourcen der 
Patienten und Umweltfaktoren, welche bei der Behandlung von Patienten mit 
Diabetes mellitus relevant sind, befragt. Die Befragung erfolgte anhand der 
Delphi-Methode in drei Runden via elektronische Post (E-Mail). Die Antworten 
der Experten wurden nach definierten Regeln von zwei darin erfahrenen 
Mitarbeiterinnen in die Fachsprache der ICF übertragen. Der Grad der 
Übereinstimmung dieser Ergebnisse wurde mit dem Kappa-Koeffizienten 
berechnet.  
Resultate: 84 Ärzte aus 38 Ländern nannten 1220 Probleme von Patienten 
mit Diabetes mellitus, die alle Komponenten der ICF abdeckten. Die Antworten 
wurden 212 ICF Kategorien zugeordnet. Von diesen Kategorien waren 22 
bislang nicht im „Umfassenden ICF Core Set für Diabetes mellitus (DM)“ 
erfasst, obwohl mindestens 75% der Teilnehmer diese als wichtig erachteten. 
45 Antworten wurden der noch nicht klassifizierten Komponente der 
„Personenbezogenen Faktoren“ zugeordnet und 11 Sachverhalte wurden 
durch die ICF Klassifikation nicht abgedeckt.  
Schlussfolgerung: Die Validität des „Umfassenden ICF Core Set für Diabetes 
mellitus (DM)“ wurde von der teilnehmenden Ärzten für die Komponenten „ 
Aktivität und Teilnahme“ und „Umweltfaktoren“ größtenteils bestätigt. Die 
Komponente der „Körperfunktionen“ und der „Körperstrukturen“ fand hingegen 
weniger Unterstützung. Es zeigten sich einige Antworten und Sachverhalte, 
die weiterer Untersuchung bedürfen. 
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2  Abstract 
 
 
Aims: The Comprehensive ICF Core Set for diabetes mellitus (DM) is a 
specific application of the International Classification of Functioning, Disability 
and Health (ICF) of the World Health Organization for clinical and research 
purposes involving the disorder. It represents the typical spectrum of problems 
in functioning of patients with DM. The objective of this study was to validate 
the Comprehensive ICF Core Set for DM from the perspective of physicians.  
Methods: A three-round electronic-mail survey using the Delphi technique was 
conducted. Physicians experienced in DM treatment were asked about the 
patients’ problems, patients’ resources and aspects of environment that 
physicians took care of. The responses were linked to the ICF. 
Results: 84 physicians in 38 countries named 1220 patients’ problems that 
covered all ICF components. 212 ICF categories have been linked to these 
answers. 22 ICF categories were not represented in the Comprehensive ICF 
Core Set for DM although at least 75% of the participants have rated them as 
important. 45 answers have been linked to the not yet developed ICF 
component Personal Factors and 11 categories were not covered by the ICF 
classification.  
Conclusion: The validity of the ICF components Activities and Participation 
and Environmental Factors has almost perfectly been supported by the 
physicians whereas there has been less support for the validity of the 
components Body Structures and Body Functions. Several issues arose that 
are not covered and need to be investigated further.  
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3  Introduction 
 
 
3.1  Definition, epidemiology, pathogenesis and classification of DM  
 
Diabetes mellitus (DM) is characterized as a collective term for various 
metabolic diseases. Strictly speaking DM is a clinical syndrome connected to 
chronic hyperglycaemia due to deficiency and/or impaired effectiveness of 
insulin action and the risk of serious organ damage up to failure over time 
(Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 
2003; Alberti et Zimmet, 1998).  
Already 1500 BC references to diabetes were written by ancient 
Egyptian physicians in the Ebers Papyrus when they describe diabetic 
symptoms without naming the disease (Papaspyros, 1964). In the following 
centuries and millennia, notably in the 19th century, the understanding of 
interweaved aspects of diabetes arose and the handling with diabetes mellitus 
and new insulin preparations developed (Ahmed, 2002; Zajac et al., 2010). 
In every region of the world you can find individuals with DM. The 
leading countries are China, India and the United States of America (IDF, 
2011). Current data from the World Health Organization and the International 
Diabetes Federation show that more than 347 million people suffer from DM 
worldwide (WHO, 2013). Predictions are that the world prevalence among 20-
79 years old adults will increase up to 439 million adults by 2030, or 7.7% of 
the analog population. The International Diabetes Federation prognosticates 
for 2030 even 552 million people suffering from diabetes (IDF, 2011; Shaw, 
2010). So far, adults aged between 40-59 years represent the major division of 
individuals suffering from DM. Actually, the difference in gender plays not a 
major role. In 2030 it is predicted that 275 million women and 277 million men 
will have DM (IDF, 2011). However, the prevalence in men is expected to be 
higher than in women (Wild, 2004). 
Another important group are children and adolescents because the 
incidence of DM, particularly type 1 diabetes, is increasing in this age group in 
many populations worldwide. Annually, about 78,000 children under the age of 
15 worldwide are expected to develop type 1 diabetes. Furthermore, there is 
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an increasing number of children and adolescents with type 2 diabetes most 
likely due to the progressive prevalence of obesity and lack of activity (Fagot-
Campagna, 2000; IDF, 2011; Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003). 
The etiologic classification splits DM into four groups (Powers, 2004): 
type 1 diabetes, type 2 diabetes, gestational diabetes mellitus (GDM) and 
other specific types due to other causes e.g. genetic defects of ß-cell function 
also known as Maturity-onset-diabetes of the young, MODY (Olek, 2006), 
genetic defects in insulin action and secondary diabetes. The latter one 
compromises inflammatory or neoplastic diseases in exocrine pancreas, 
endocrinopathies like acromegaly or Cushing’s syndrome, drug- or chemical-
induced diabetes caused by nicotinic acid or glucocorticoids (Powers, 2004), 
infections like congenital rubella or cytomegalovirus, uncommon forms of 
immune mediated diabetes like the “Stiff-man”-syndrome or other genetic 
syndromes sometimes associated with diabetes like Down’s syndrome, 
Klinefelter’s syndrome or Turner’s syndrome. Based on this etiologic variety 
the development of DM is caused by several pathogenetic processes 
originating from an inadequate effect of insulin on target tissues (Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003). 
Furthermore, there exist intermediate levels of glucose intolerance like 
impaired glucose tolerance (IGT) and impaired fasting glucose (IFG). 
Therefore, individuals with these intermediate levels do not suffer from DM. 
These types share some characteristics with type 2 diabetes, e.g. the 
connection with excessive weight increase, insulin resistance and insulin 
secretory malfunctions. They have a much higher risk for developing type 2 
diabetes and cardiovascular disease (CVD) in the following years (Alberti, 
1996; IDF, 2011). 
Type 1 diabetes shows a deficiency of insulin secretion because of a 
cellular-mediated autoimmune destruction of the insulin-producing ß-cells of 
the pancreas. It appears in 5-10% of those with diabetes, particularly in 
children, but it may occur in any age of life. Additionally, this form could also 
arise idiopathic without any indication of autoimmunity (ADA, 2012). Currently, 
no prevention is known partly because the mechanism of type 1 diabetes is not 
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fully understood. Nevertheless this form of DM is an established endocrine and 
metabolic disease in childhood (IDF, 2011; WHO, 2013). 
In relation to all diabetes cases type 2 diabetes represents up to 95%. 
An essential characteristic of this form of diabetes is its wide spread range 
from insulin resistance with relative insulin deficiency to an insulin secretory 
defect. In general, type 2 diabetes appears after the age of 40 years. The 
appearance and the manifestation of type 2 diabetes are noticeably associated 
with a lack of physical activity and obesity or increased percentage of visceral 
body fat (ADA, 2012; WHO, 2013). This intraabdominal fat, the emerging 
insulin resistance towards the insulin-dependent tissues like the muscle-cells 
and the compensatory hyperinsulinaemia in tissues leads to metabolic 
disorders and finally to the metabolic syndrome. This syndrome is a cluster of 
associated risk factors and goes along with type 2 diabetes, atherosclerosis 
and cardiovascular diseases (Duvnjak et Duvnjak, 2009). 
In addition, it is important to look at the DM occurrence in a family due 
to the high heritability. The pathogenesis of type 2 diabetes is a result of 
environmental and multiple genetic factors. In the last years several studies 
have identified a multiplicity of susceptibility loci of the genome associated with 
type 2 diabetes (Sladek et al, 2007; Palmer et al, 2012; Patel et al, 2013; Scott 
et al, 2007; Sanghera et Blackett, 2012; Unoki et al, 2008). Although there is a 
clearly strong genetically incidence, the exact pathway of heredity is not 
identified yet (Hansen, 2003). However, a risk prediction for developing type 2 
diabetes in adults based only on the analysis of the genes should currently not 
be supported due to less specificity (Vassy et Meigs, 2012).  
The worldwide increase in incidence and the long-term consequences 
of this illness make DM a medical problem first grade (Harris et al, 1998; Geiss 
et al, 2006). Moreover, it is an expensive disease. In 2011 about 11% of the 
worldwide total healthcare expenditures refer to DM. Considering global 
differences in purchasing power, the global expenditures expressed in 
International Dollars (ID) were 499 billion in 2011. It is estimated that 2030 this 
rate will increase to ID 654 billion. In contrast to the world’s economically 
richest countries the developing countries have to pay a larger percentage of 
the accumulating expenditures because their medical care systems are less 
developed. In addition, the loss in productivity and economic growth due to the 
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loss of gains, work days, a lower productivity at work, mortality and the 
disability induced by DM costs even more billion US Dollars. The largest 
economic damage regarding DM is followed from disability, loss of life and the 
diabetes complications (IDF, 2011). 
 
 
3.2  Clinical features, complications and treatment of DM 
 
Currently, three criteria for the diagnosis of DM exist: elevated fasting 
glucose, abnormal oral glucose tolerance test and elevated random plasma 
glucose concentration with symptoms of DM.  
The symptoms of DM could be just as various as their complications 
and are mostly accompanied by them (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003; Alberti et Zimmet, 1998). They 
appear in people with type 1 diabetes almost immediately and severe with 
hyperglycaemia and ketoacidosis (ADA, 2012; IDF, 2011). In contrast, people 
with type 2 diabetes often develop hyperglycaemia rather successively and in 
stages. Since typical symptoms are often less pronounced, the diagnosis of 
type 2 diabetes may be delayed (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003). The typical appearance of people 
with type 2 diabetes is an overweight person. Diabetic symptoms include in 
many cases unspecific general symptoms like fatigue, loss of efficiency, 
abnormal appetite and sweating. Polyuria and polydipsia are the 
consequences of osmotic diuresis resulting for glucosuria as well as the 
following thirst (WHO, 2013; Roche et al, 2005). Some patients with hidden 
DM are incidentally diagnosed by skin infections or infections of the urinary or 
genital tract (Fonseca et John-Kalarickal, 2010). Furthermore, the quality of life 
in men with DM could be impacted by modified sexual dysfunction, which 
exists in more than 50% of patients with DM (Penson et al, 2003).  
A familiar problem in diabetic patients is the cutaneous appearance of 
DM with a frequency of about 30% in the course of the disease (Ahmed et 
Goldstein, 2006). The skin involvement shows many different shapes like the 
rare disease necrobiosis lipoidica diabeticorum (Pestoni et al, 2003) or the 
most common diabetic dermopathy (Shemer et al, 1998). Furthermore, 
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diabetic pharmacological management e.g. with Sulfonylureas or Insulin can 
provoke unrequested skin reactions with pruritus, erythema and lipoarthophy 
or allergic skin reactions (Sood et James, 2000). The dreaded skin problem of 
the so-called diabetic foot is the result of manifold pathological processes and 
develops because of diabetic neuropathy with motoric and sensory 
involvement, insufficient blood circulation and ischaemia. Mostly there is an 
initiating injury which results from thermal, acute or chronical mechanical origin 
(Boulton, 1988; Cavanagh et al, 2005) combined with concomitant risk factors 
resulting in an exacerbated and complicated infection of the foot ulcer to limb 
or even life-threatening situations (Hampton, 2006).  
Additionally, there is a rare development due to complex changes of the 
diabetic foot into the transformation to a charcot foot with bone and joint 
destruction and following foot deformity (Rajbhandari et al, 2002). Despite of 
the availability of good foot care management there is a 15 times higher overall 
risk of amputation compared to persons without DM (Most et Sinnock, 1983). 
However, the dermatological problems of patients with DM are in a lot of cases 
bacterial and candidal skin infections (Ahmed, Muhammad et Qayum, 2009) 
regularly seen in poorly controlled diabetics. Potential reasons for the 
disposition for infections are again complex and range from vascular 
insufficiency and neuropathy to impairment of immune response (Ahmed et 
Goldstein, 2006; Wheat, 1980). 
Over the time DM can damage many different organs and tissues in the 
body, which leads to various acute or chronic complications. Due to the 
delayed diagnosis in lots of people with undetected and initially asymptomatic 
type 2 diabetes, the first recognized disorders could be characteristics of the 
so far hidden and associated complications. These problems and 
complications are basically related to damages of the vasculature called 
macro- and microangiopathy (Alberti et Zimmet, 1998). The morbidity, the 
mortality and the disability in people with type 2 diabetes are highly associated 
with macrovascular problems including coronary arterial disease, 
cerebrovascular disease as well as peripheral vascular disease. 
Arteriosclerosis and consequently macroangiopathic conditions arise earlier 
and more rapidly in people with DM because of the high influence of 
hyperglycaemia, hyerinsulinaemia and insulin resistance (Massi-Benedetti et 
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Federici, 1999; UKPDS Group, 1998; Nishimura, 2011). DM has a multiplying 
effect on the cardiovascular risk in the presence of other cardiovascular risk 
factors like hypertension or dyslipidaemia. Due to the fact that the 
cardiovascular disease is the main reason of morbidity and mortality in DM 
there is a need to include glycaemic control to the relevant variables like the 
classical risk factors as blood pressure, dyslipidaemia and smoking to appraise 
the cardiovascular disease and atherosclerosis risk (Fuller et al, 2001; 
Avogaro,2007; Sowers, 2001). Not only the higher risk to get a myocardial 
infarction compared to the general population but also the one-year mortality 
after a myocardial infarction is notably higher in patients with DM. Furthermore, 
succumbing sudden cardiac death is more likely in diabetic patients with a 
myocardial infarction and also having an increased risk of death from 
cardiovascular disease is more frequent as in non-diabetics (Pappone et 
Santinelli 2010; Boudina et Abel, 2010; Miettinen et al, 1998). Particularly 
diabetic women have a higher possibility of death from stroke and in 
association with that the duration of DM collaborates to the risk of sustaining a 
stroke. A reduction as little as 5 - 6 mmHg of the diastolic blood pressure is 
connected with one-third fewer strokes and one-fifth fewer coronary heart 
disease events (MacMahon, 1990; Almdal, 2004; Tuomilehto, 1996).  
The microangiopathy, the damage of the small vasculature strongly 
correlates with the duration of DM, glycaemic control as well as blood pressure 
and lipid control (Girach et al, 2006; Girach et Vignati, 2006). Endothelial 
dysfunction and a lot of other complex intracellular signaling mechanisms 
induce complications in different parts of the body and the outcomes include 
the characteristic diabetic nephropathy, diabetic retinopathy, diabetic 
neuropathy and small vessel disease (Hadi et Suwaidi, 2007; UKPDS Group, 
1998).  
The worldwide increased incidence of diabetic nephropathy shows that 
in developed countries up to 50% of the patients with end-stage renal disease 
(ESRD) are patients with DM (Ritz et al, 2011). Main predictors of diabetic 
nephropathy up to ESRD are progressive albuminuria, high blood pressure, 
smoking and poor glycaemic control. The first clinical sign of diabetic renal 
affection is microalbuminuria, which should signalize the start of appropriate 
interventions in order to prohibit the development of nephropathy. It is also an 
14 
 
important risk factor for coronary heart disease and stroke in patients with DM 
because this marker reflects endothelial dysfunction and elevated oxidative 
stress. The complexity of pathogenesis and evolution of the diabetic 
nephropathy leads to multi-level interventions in therapy to avoid the 
threatened and often deadly ESRD and the potential early haemodialysis or 
renal transplantation (Ritz, 2006; Ritz et Tarng, 2001; Hadi et Suwaidi, 2007).  
A further microvascular complication is the diabetic retinopathy. It is 
more precisely characterized as nonproliferative or proliferative retinopathy 
with typical vascular modifications in the funduscopic examination. Its 
development is strongly dependent on the duration of hyperglycaemia and DM. 
After 15 years of DM visual impairment and the prevalence of proliferative 
diabetic retinopathy increases up to 25%. Even 1 % suffers from blindness 
globally due to diabetic changes (WHO, 2012; Cowie et al, 2006). The 
treatment and prevention strategies to lower the risk of developing and 
exacerbating diabetic retinopathy and preventing severe vision loss range from 
control of blood pressure and blood sugar, several medications to laser 
photocoagulation and vitrectomy (Wilkinson-Berka et Miller, 2008).  
Microvascular complications also affect different parts of the nervous 
system resulting in diabetic neuropathy. At the time of DM diagnosis the 
prevalence is about 10% (Boulton et al, 2005). Thomas (1997) and Boulton et 
al (2005) classify diabetic neuropathy into generalized symmetric 
polyneuropathies, focal and multifocal neuropathies. The most common 
diabetic neuropathies are the chronic sensorimotor distal polyneuropathy 
(DPN) and the autonomic neuropathy (DAN) which belongs to the generalized 
symmetric polyneuropathies. The typical symptoms of DPN like burning and 
stabbing pain, electrical sensations, paraesthesia or hypersensitivity are 
commonly located in the lower limbs and in the feet. A careful clinical 
examination is necessary in order to discover problems such as sensory loss 
of vibration, pressure, pain and temperature. Loss of ankle reflexes, autonomic 
dysfunctions like warm or cold feet, dry skin, wound healing disorders and 
painless ulcers are also characteristic signs (Boulton et al 2005). The diabetic 
autonomic neuropathy (DAN) regarding the sympathetic and parasympathetic 
nervous system influences a variety of organ systems. DAN is associated with 
increased mortality not least due to that fact that the autonomic neuropathy 
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affects the cardiovascular system (CAN) and can induce silent myocardial 
ischaemia and cardiovascular death. Possible further complications are related 
to the gastrointestinal tract, the sexual organs or could appear as unsuspicious 
symptoms like anhidrosis or just dry skin (Vinik et al, 2003).  
Regarding the possible acute complications of DM the diabetic 
ketoacidosis (DKA) and hyperosmolar hyperglycaemic state (HHS) have to be 
considered. The clinical presentation of these patients is heterogeneous, 
ranging from thirst, nausea, vomiting, abdominal pain, increased urinary 
excretion, dehydration with signs of shock, weakness to dizziness resulting in 
coma and in case of DKA additionally with a sweet acetone-like breath and a 
rapid Kussmaul respiration. The mortality rate in DKA is in maximum 5% and in 
HHS about 15% (ADA, 2001). The factor that mediates decompensation 
possibly leading to multiple organ failure, brain edema and death is relative or 
absolute insulin deficiency. Infections like pneumonia, several medications like 
corticosteroids or simply an irregular use of insulin could start these severe 
metabolic disturbances. The treatment should be in an intensive care setting 
with an aggressive rehydration, electrolyte adjustment and particularly in case 
of DKA, efficient use of insulin and correction of the metabolic acidosis 
(Kitabchi et al, 2001). 
A differential diagnosis of the diabetic comatose state is the 
hypoglycaemic coma. The blood glucose level decreases below 30 mg/dl 
(circa 1.6 mM/L) and can produce seizures and neurologic problems leading to 
death. In fact for patients suffering from DM hypoglycaemia with neurogenic 
and neuroglycopenic symptoms is a common problem because of e. g. 
insufficient insulin management, missed food uptake or increased exercise 
without adapting the antidiabetic drugs (McAulay et al, 2001; Davis 2010). 
 
The treatment of DM as a chronic disease is complex und multifactorial. 
All aspects of prevention to avoid type 2 diabetes, to avoid and treat metabolic 
disorders und to treat diabetes-related illnesses have to be considered. A 
multidisciplinary physician-led cooperation is essential including diabetologists, 
endocrinologists, general practitioners, podiatrists, nurses, dental specialists, 
dietitians, physical therapists, rehabilitation specialists and other health 
professionals with expertise in DM. Diabetes associations and the national 
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health care system make also important contributions. The American Diabetes 
Association (ADA) established clinical practice recommendations and the 
International Diabetes Federation (IDF) developed a global guideline for type 2 
diabetes. Additionally to the extended medical care the diabetes self-
management by each patient is essential (Funnell, 2012; IDF, 2012; ADA, 
2013). 
The main target of treatment in DM is glucose monitoring; particularly 
the self-monitoring of blood glucose (SMBG) is a component of effective 
therapy. As a glycaemic goal the A1C level, as an index of chronic glycaemia, 
should stay below 7%. Depending on the value of hyperglycaemia or new-
onset type 2 diabetes, an oral glucose lowering medication has to start if 
lifestyle interventions such as weight loss, dietary change and increased 
physical activity failed to stabilize the target levels of blood glucose. The so-
called first line therapy includes medication with one oral agent e.g. metformin. 
In the second line up to fourth line therapy the addition of other oral agents like 
sulfonylurea or the addition of insulin is recommended (IDF, 2012; ADA, 2013). 
Moreover, screening and treatment of DM complications is indispensible as 
well as the preventive treatment options like medical nutrition therapy (MNT), 
diabetes self-management education (DSME), psychosocial assessment and 
care, immunization against special infections or even the possibility of bariatric 
surgery. To optimize interventions aimed at maintaining functioning and 
minimizing disability, a proper understanding of the patients’ functioning and 
health status is needed.  
 
 
3.3  The International Classification of Functioning, Disability and Health  
 
The International Classification of Functioning, Disability and Health 
(ICF) belongs to the international classifications developed by the World 
Health Organization (WHO). Based on a revision of the International 
Classification of Impairments, Disability and Handicaps (ICIDH) published in 
the 1980s, in May 2001 the ICF was announced for international use by the 
54th World Health Assembly. Health conditions, diseases and disorders are 
basically represented in the worldwide well-known tenth revision of 
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International Classification of Diseases (ICD-10) to schedule them and to 
provide a diagnosis which is used as a diagnostic implement for health 
management, clinical purposes and epidemiology (WHO, 2011). 
Complementary to the ICD-10, the ICF reflects functioning and disability which 
are indispensable connected to each health condition. The ICF provides 
detailed and systematic information about all bio-psycho-social aspects of 
consequences of illnesses and disorders in consideration of the relevant 
contextual factors. To describe sufficiently health states and the need of 
rehabilitation resulting from all different disorders the ICF complements the 
ICD-10. Using both classifications, the health status of the population can be 
specified and compared at national and international levels.  
The ICF aims at generating a uniformed language and a standardized 
coding scheme for the description and classification of health and health-
related states to develop and improve the communication between health 
professionals, researchers as well as the public. It also provides a universal 
framework for health information systems and health outcome measurement 
(WHO, 2001). The application of the ICF is diversified and comprehensive. It is 
used e.g. in the statistical, research, clinical or social policy sector as well as in 
the scope of insurance, education, economical or environmental modification. 
Overall, the aims of the ICF are orientated towards an understanding of the 
patient’s needs and situation to improve therapy and rehabilitation.  
 
The ICF organizes information regarding human functioning and its 
limitations in two parts. The first part deals with functioning and disability which 
is divided into Body Functions (b) and Body Structures (s) as well as Activities 
and Participation (d). In the second part the Contextual Factors are included 
which are split in two parts Environmental Factors (e) and Personal Factors. 
Regarding their association with social and cultural variety Personal Factors in 
the ICF such as gender, habits, coping style, age or education are not 
classified yet. The component Body Functions refers to the physiological and 
psychological alterations of the body, whereas Body Structures describe 
changes in the anatomical parts like organs or extremities. Both components 
are created to work together side by side.  
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The component Activities and Participation deals with tasks and actions 
of a person and consequently with the possibility to execute, perform and to 
have the capacity to do them including the individual and environmental 
perspective. The distance between capacity and performance to solve 
problems in an individual demonstrates effectively what can be done to the 
environment to optimize the performance. The component Environmental 
Factors represents external influences on functioning and disability of an 
individual which facilitate or cumber physical, social and psychic issues. These 
influences can be found in the direct environment of a person like home, 
workplace and school and include also social structures, services such as 
organizations, government agencies and laws (WHO, 2001).  
 
 
 
Figure 1: The integrative biopsychosocial model of the ICF (WHO, 2001) 
 
 
This multidimensional approach to merge different perspectives of 
health and health-related problems is described as a biopsychosocial model 
arising from synthesis of the medical model and the social model. Body 
Functions and Body Structures as well as Activities and Participation interact 
between the Health condition as a disorder or disease and the Contextual 
Factors Environmental Factors and Personal Factors (see figure 1). 
 
Health condition  
(disease, trauma) 
Environmental 
factors 
Personal factors 
Contextual factors 
Activities 
Body functions 
Participation 
Body structures 
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The ICF is systematically organized with the help of interlinked levels 
and hierarchic alignment. Each component has a letter code for characterizing 
(b, s, d and e) and consists of a numeric succession of chapters which are 
arranged in a reasonable way and suitable to their common characteristics. 
This sequence of chapters represents the first level of classification. Within 
every chapter more detailed levels can be reached. The ascending second, 
third and fourth level in each component describes even more specific the 
human functioning and disability. Hence, the letter abbreviation for each 
component is followed by a numeric code consisting in a maximum of five 
digits representing the levels. Therefore, more detailed higher-leveled 
categories comprise all the aspects applicable for the lower-leveled category of 
which it is a member, but not contrariwise. Figure 2 shows the general 
structure of the ICF as a stem-branch-leaf-order. 
To complete the ICF code the severity of the health condition is marked 
as a number ranging from zero to four. This number, known as qualifier, is 
added after a point to the relevant category and is increasing with the 
seriousness of the disease (WHO, 2001).  
 
The application of this full length ICF classification with 1454 categories 
in clinical routine is illustrated for a number of health conditions, including DM, 
with the development of simplified versions, namely the ICF Core Sets (Ruof et 
al, 2004). A collaborative project of the ICF research branch of the WHO FIC 
Collaborating Center (DIMDI) at the Department of Physical Medicine and 
Rehabilitation of the Ludwig-Maximilians-University in Munich with the 
Classification, Assessment, Surveys and Terminology Group (CAS) of WHO 
and several worldwide partner organizations evolved from the whole ICF 
classification this internationally accepted and empirically based ICF Core Sets 
(Üstün et al, 2004; Stucki et Grimby, 2004; Cieza et al, 2004; Stucki et al, 
2002). 
These lists of ICF categories for specific conditions can serve as 
Comprehensive ICF Core Sets which contain the characteristics and detailed 
scope of problems in functioning in patients relating to the corresponding 
health-state e.g. to guide multidisciplinary assessments or as Brief ICF Core 
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Sets to describe the problems in a more shortened way with a small number of 
categories for a better practical use e.g. in clinical studies (Cieza et al, 2004).  
 
 
Figure 2: Structure of the International Classification of Functioning, Disability 
and Health; hierarchical arrangement (modified figure, WHO, 2001) 
 
 
 
The development of the ICF Core Sets for each health condition 
assembled from the view of different involved health professionals followed a 
standard approach including a formal decision-making and consensus process 
detecting evidentiary information from expert opinions and preparatory studies. 
The method educing the perspective of experts, researches and patients used 
the Delphi technique, a systematic review and an empirical data collection 
(Cieza et al, 2004; Weigl et al, 2004). Weigl et al. reported the identification of 
57 ICF categories as most typical and relevant categories for patients with DM 
in a Delphi exercise.  
Furthermore, a systematic review with the analysis of outcome 
measures of 227 randomized controlled trails on DM and 19 different health 
status questionnaires was implemented between the years 1993 and 2003. 
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After identification and comparison of the extracted concepts they were linked 
to the ICF (Wolff et al, 2004). More data was collected in a multi-centre, cross 
sectional study using the ICF checklist on 67 patients with DM to identify the 
most common problems due to their health condition. Altogether, the collected 
data of these pre-conference studies (Weigl et al, 2004; Wolff et al, 2004; 
Ewert et al, 2004) regarding the health condition DM showed 99 ICF 
categories from Body Functions, 40 from Body Structures, 55 from Activities 
and Participations and 59 from Environmental Factors.  
In the following International ICF Core Sets Consensus Conferences in 
2003, 15 international experts from nine different countries identified the most 
relevant ICF categories for the ICF Core Sets for DM (Ruof et al, 2004; Cieza 
et al, 2004). In conclusion, the Comprehensive ICF Core Set includes 99 
categories with 36 categories regarding Body Functions, 16 categories from 
Body Structures, 18 from Activities and Participations and 29 from the 
component Environmental Factors. The Brief ICF Core Set of DM includes 
altogether 33 second-level categories, namely 12 applying to the Body 
Functions, six to Body Structures, five to Activities and Participation and ten 
regarding the Environmental Factors (Ruof et al, 2004).  
 
Patients with chronic diseases including DM need intensive, 
professional and interdisciplinary treatment and care. The advantages of 
multidisciplinary care assume a competent interconnected collaboration of 
different parties of the health care system. The collaboration of clinicians, 
patient educators, medical specialists and other health professionals permits 
an exchange of information and coordination of therapeutic procedures 
(Wagner, 2000).  
In a population-based study differences were assessed in processes of 
care between different health care specialists and suggested that diabetic care 
can be improved (Gnavi et al, 2009). Therefore the constant proceeding 
improvement of quality of care and the therapeutic approach demand a 
common language and reference system to ensure interprofessional 
communication and simplifying multidisciplinary responsibility (Steiner et al, 
2002). 
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Figure 3: Comprehensive ICF Core Set for DM 
 
 
The ICF comprising the Comprehensive ICF Core Set for DM supplies a 
useful tool in cross-linking this interdisciplinary health care and rehabilitation 
system. With this classification it is possible to describe the impairments of 
respective patients with DM, the limitations and restrictions in participation and 
activities of the daily life as well as the affecting environmental factors. 
Consequently it is possible to construct a functioning profile which can be used 
for follow-up (Cieza et Stucki, 2006).  
 
 
3.4  Objective 
 
So far, a variety of worldwide tests and studies has been performed and 
confirmed the importance, accurateness and application of the ICF Core Sets 
in clinical practice and research. Different approaches were used to reach this 
aim. The validation of the so far existing ICF Core Sets is an ongoing process.  
The worldwide testing of the content validity of the Comprehensive Core 
Set for DM includes international multi-center validation studies and validation 
from the different perspectives of health professionals as well as from the 
patients’ point of view (Kirchberger et al, 2009; Awad et al, 2009; Abdullah et 
al, 2011). The particular interest applies to the validation from the perspective 
of the user especially the physicians as a guide in the management of DM. 
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The reflection of the patients’ needs and treatment approaches in the different 
categories of the Comprehensive Core Set from the physicians’ perspective is 
highly necessary since the ICF Core Sets should provide a standard for 
multiprofessional assessment in clinical trials.  
The objective of this study was to validate the Comprehensive ICF Core 
Set for DM from the perspective of physicians. Using this approach the study 
initially intends to identify the patients’ problems, resources and environmental 
issues treated by physicians. The representation of these aspects by the 
current version of the Comprehensive ICF Core Sets for DM was finally tested. 
 
 
 
4  Methods 
 
 
4.1  The Delphi method 
 
An electronic-mail survey of physicians was performed in three rounds. 
The method of this survey used the Delphi technique (Linstone et al, 1975; 
Duffield 1993; Goodman, 1987). The Delphi method was designed in the 
1950s and was made for organizing and structuring a group communication 
process by developing a systematic multi-stage survey.  
The achievement of consensus from a panel of commonly titled 
‘experts’ is the principal aim of the Delphi technique. The ‘experts’ are 
individuals, who have knowledge of the investigated area of research 
(McKenna, 1994; Crisp et al, 1999; Snyder-Halpern et al, 2000).  
The Delphi method is a multi-stage process where each stage builds on 
the results of the previous one. The development of a questionnaire is the 
starting point of collecting information about a particular subject. Each single 
questionnaire gathers the descriptions of the respective participant in a series 
of successional rounds, in this case three rounds. After returning the fulfilled 
questionnaires the results of the particular round are summarized and the 
outcome of this open up into another new questionnaire heralding the next 
round. Avoiding the dominance of single participants in a group the technique 
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is characterized by its anonymity. Free phrasing of the own opinion is allowed 
by each individual. The different rounds as a term of iteration permit the panel 
members to re-examine and change their opinions in the following rounds. 
Furthermore, the controlled feedback shows the distribution of the group’s 
responses as well as each individual’s previous responses.  
Consensus methods such as the Delphi technique have the benefit of 
being suitable for participants in areas where published information is difficult 
to achieve. It is necessary to consider the geographical conditions because 
they could limitate a sufficient participation in this study. A further positive 
effect resulted from the respect of time and costs (Linstone et al, 1975; Adler 
et Ziglio, 1996). Moreover, this consensus method is more appropriate for 
extensive ranges of information than statistical models (Jones et Hunter, 
1995). 
 
 
4.2  Recruitment of participants 
 
In the initial phase of the survey experts in diabetes treatment were 
identified. It was essential that all WHO defined world regions are represented 
in the expert sample. A total of 233 international and national diabetes 
associations, 506 individual experts and 13 former cooperation partners of the 
ICF Research Branch Munich were identified and contacted. All associations 
and 163 individual experts have been found by internet search, 336 experts by 
literature search and seven experts were named by other colleagues or 
associations. Only experts with available e-mail and/or fax number had been 
included. 
In the cover letter of the preparatory phase of the study it was pointed 
out that the participants should be “physicians experienced in the treatment of 
diabetes mellitus” to assure that the connected experts are ‘informed 
individuals’ with sufficient expertise. Experts were selected using the method 
of Purposive Sampling. In this sampling method, the researchers’ knowledge 
about a population is the basis for the decision which persons should be 
included in the sample (Tongco, 2007). The first contact consisted of an email 
including an invitation to participate and detailed information about the aims of 
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the project, the Delphi process and the timeline. Only persons who agreed to 
participate had been included in the expert sample and received the 
questionnaire for the first Delphi round (see attachment 10.2). 
 
 
4.3  Delphi process 
 
The process and the verbatim questions of the electronic-mail survey 
are displayed in figure 4. The participating experts had overall three weeks to 
return their responses for each Delphi round. Reminders in a form of an email 
notice were sent about one week before deadline, at the day of the deadline 
and two days after deadline, when necessary. 
 
In round 1 of the Delphi process an information letter including study 
instructions and an Excel file containing an open-ended questionnaire were 
sent to all participants. In this questionnaire the participants were asked to list 
all the patients’ problems, patients’ resources and aspects of environment 
treated by physicians in patients with DM. In addition, the experts were asked 
to respond to questions on demographic characteristics namely gender and 
age as well as their professional experience, the experience with DM and their 
self-rated expertise on this disorder (see attachment 10.2). The replies were 
gathered, the basic concepts identified and finally linked to the ICF.  
 
In the second Delphi round, a list of the ICF categories linked to the 
responses of the first round (see attachment 10.3) were sent to the experts. 
The listed ICF categories were ordered according to the structure of the ICF. 
The experts’ responses which could not be connected to an existing ICF 
category were classified by the research team and listed as Personal Factors, 
health conditions or categories not yet classified by the ICF. The participants 
were requested to agree or disagree in the questionnaire whether the 
respective ICF category represents patients’ problems, patients’ resources or 
aspects of environment treated by physicians in patients with DM. 
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Figure 4: Description of the Delphi-exercise 
 
 
 
In the third and last Delphi round the participants received by email a 
list of the ICF categories including the quota and the identification numbers of 
the participants who did agree that the categories represent patients’ 
problems, patients’ resources or aspects of environment treated by physicians 
in patients with DM (see attachment 10.4). The participants were requested to 
answer the same question as in round two but considering the responses of 
the group as well as their previous response.  
 
 
 
Question: 
What are the patients’ problems, patients’ 
resources and aspects of environment treated by 
physicians in patients with DM? 
Round 1 
- Linking of answers to 
ICF 
- Feedback of ICF 
categories (Code, 
title, description of 
content) 
 Question: 
Do you agree that this ICF category represents 
patients' problems, patients' resources or aspects 
of the environment treated by physicians in 
patients with DM? 
Round 2 
- Calculation of 
frequencies 
- Feedback of 
individual and group 
answer 
Question: 
Taking into account the answer of the group and 
your individual answer in the second round, do 
you agree that this ICF category represents 
patients' problems, patients' resources or aspects 
of the environment treated by physicians in 
patients with DM? 
Round 3 
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4.4  Linking 
 
An ICF category is coded by the component letter and a suffix of one to 
five digits. The letters b, s, d, and e refer to the components Body Functions 
(b), Body Structures (s), Activities and Participation (d) and Environmental 
Factors (e) (see figure 1). This letter is followed by a one digit number 
indicating the chapter, the code for the second level (two digits) and the third 
and fourth levels (one digit each).  
Within each component, the categories are arranged in a stem-branch-
leaf scheme (WHO, 2001). Consequently a higher-level (more detailed) 
category shares the aspects of lower-level categories of which it is the 
member, so the use of a higher-level category implies that the lower-level 
category is applicable, but not vice versa. 
To demonstrate the use of letters and digit numbers, an example is 
shown below: 
 
 
Component   b  Body Functions 
 
Chapter (1st level)  b2  Sensory functions and pain 
 
2nd level    b280  Pain 
 
3rd level    b2801  Pain in body part 
 
4th level    b28015 Pain in lower limb 
 
 
Each response of the first Delphi round was linked to the most precise 
ICF category. The linkage was performed by a trained doctoral student on the 
basis of 10 linking rules, established in previous studies (Cieza et al 2002; 
Cieza et al, 2005). For example categories containing the expression “other 
specified” or “not specified” or “no specified” as well as all ending by the 
numbers “eight” and “nine” were not used. In such cases a lower leveled, less 
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precise category was applied. Concepts related to health or quality of life in 
general were classified as “nd-gh” (not definable-general health) or “nd-qol” 
(not definable-quality of life). Moreover, concepts that are not included in the 
ICF as a category, but defined as a Personal Factor by the classification were 
listed by “pf”. If the concept contained a diagnosis or health state, “hc” (health 
condition) was assigned to it. Finally, concepts neither included in the ICF nor 
describing a personal factor were declared “nc” (not covered).  
If a response contained more than one concept, several ICF categories 
could be linked. 50% of the responses were linked separately by two trained 
health professionals. Consensus between the health professionals was used 
to decide which ICF category should be linked to each response. In case of 
disagreement between the two health professionals, the suggested categories 
were discussed by a team consisting of three health professionals. Based on 
this discussion a joint decision was made. The whole linking procedure 
including the four linking steps is explained in table 1. 
 
 
4.5  Statistical methods 
 
Statistical analysis was performed using SAS for Windows V8. 
Descriptive statistics were used to characterize the sample and frequencies of 
responses. Kappa statistics with bootstrapped confidence intervals were used 
to describe the agreement between the two individuals who performed the 
linking (Cohen, 1960; Vierkant, 2004).  
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Table 1: Example of the four linking steps 
 
 Step 1  Step 2 Step 3  Step 4 
Answer of 
the 
participant 
Identified 
concept 
linker A 
Identified 
concept 
linker B 
Agreed on 
concept 
Linked ICF 
category 
linker A 
Linked ICF 
category 
linker B 
Agreed 
on ICF 
category 
Poor dietary 
knowledge 
Poor dietary 
knowledge 
Poor dietary 
knowledge 
Poor dietary 
knowledge 
pf pf pf 
Diabetic  
foot ulcers 
Diabetic 
foot ulcers 
Diabetic 
foot ulcers 
Diabetic 
foot ulcers 
b810 
s8104 
b810 
s8104 
b810 
s8104 
Herbal 
treatment 
Herbal 
treatment 
Herbal 
treatment 
Herbal 
treatment 
e5800 e1101 
e5800 
e1101 
learning of 
specific 
skills 
related to 
self 
monitoring 
of blood 
glucose 
 
learning of 
specific 
skills 
 
self 
monitoring 
of blood 
glucose 
 
learning of 
specific 
skills 
related to 
self 
monitoring 
of blood 
glucose 
 
learning of 
specific 
skills 
 
 
learning self 
monitoring 
of blood 
glucose 
d1551 
 
 
 
d1551 
d5702 
 
 
 
d1551 
 
 
 
d1551 
d5702 
 
 
 
d1551 
 
 
 
d1551 
d5702 
 
 
 
 
 
 
5  Results 
 
 
5.1  Recruitment and participants 
 
Two hundred thirty three associations specialized in DM from 146 
different countries found by internet research were contacted in the first 
selection. Seven associations forwarded our invitation to their members or 
other experts and societies. One of them sent the invitation email to all 
physicians in their electronic database. Another association named one expert, 
who was contacted and shared in the study as well.  
Finally, 26 physicians from four different associations agreed to 
participate. One hundred and sixty three single experts were found by further 
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internet search and 18 of them agreed to participate in the study. By literature 
search 336 experts had been contacted of whom 55 approved participation. 
Another four participants have been named by other professionals. 
Furthermore 13 former cooperation partners of the ICF Research Branch 
Munich were informed of which one refused its participation and three failed 
email delivery. 
Out of the finally 103 physicians from 43 different countries who had 
agreed to participate in this study and agreed to provide information for the 
research on the Comprehensive ICF Core Set for DM 84 physicians (81.6%) 
returned a completed first round questionnaire.  
The percentage of German participating physicians was 7.8%, 
demonstrating no overrepresentation although being a study established in 
Germany. Though the rate of European participants amounts 34.5% in the first 
Delphi round they did not significantly differ from the other participating 
physicians in terms of demographic and professional characteristics. 
Moreover, there existed no significant changes of demographic sample 
characteristics regarding the attrition of participants during the three Delphi 
rounds. The demographic data and professional characteristics of the 
participating experts are shown in table 2 and in figure 5. 
 
 
5.2  Delphi process 
 
In the first Delphi round 84 experts from 38 countries named 1220 
patients’ problems, patients’ resources or aspects of environment treated by 
physicians in patients with DM. Seventy nine of 84 participants (94.0%) filled in 
the second-round questionnaire and the third-round questionnaire was 
completed by 76 of 79 participants (96.2%). These results including the 
percentage of agreement among the participants are shown in tables 3 – 9.
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Table 2: Attrition of participants between the Delphi rounds, demographics and professional experience of the round 1 participants 
 
WHO Region Round1 
 
(n) 
Round2 
 
(n) 
Round3 
 
(n) 
Female 
 
(%) 
Age 
 
 
 
 
Median 
(Min-Max) 
Professional  experience 
[years] 
 
 
 
Median 
(Min-Max) 
DM  
Experience 
[years] 
 
 
Median 
(Min-Max) 
Self-rating 
Expertise 
DM # 
 
 
Median 
(Min-Max) 
Mainly 
treating 
patients in 
acute  
situations  
 
(n) 
Mainly 
treating 
patients in 
early- 
postacute  
situations 
(n) 
Mainly 
treating 
patients in 
chronic 
situations  
 
(n) 
 
African  
Region
1
 
6 6 6 50.0% 
 
48.5  
(39-62) 
23.0  
(15-35) 
20.0*  
(10-30) 
4.5  
(3-5) 
6 3 6 
 
Eastern  
Mediterranean 
Region
2
 
6 5 4 16.7% 
 
48.0 
(43-60) 
 
22.0  
(6-30) 
14.5  
(12-25) 
4.75  
(3-5) 
4 4 6 
 
European 
Region
3
 
29 27 26 34.5% 
 
45.0 
(38-55) 
 
18.0  
(7-30) 
15.0 
(4-29) 
4.0*  
(3-5) 
16 15 29 
 
Region of the 
Americas
4
 
10 9 9 40.0% 
 
48.5  
(43-56) 
 
21.0  
(15-25) 
18.0 
(10-23) 
5.0  
(4-5) 
1 2 10 
South East 
Asia Region
5
 
18 17 16 11.1% 
 
52.0  
(45-63) 
25.0  
(17-35) 
19.5  
(9-31) 
4.6  
(1-5) 
17 13 18 
 
Western 
Pacific 
Region
6
 
 
15 15 15 46.7% 
42.0 
(28-56) 
10.0  
(4-30) 
10.0  
(3-28) 
3.0  
(3-5) 
2 3 13* 
Total 84 79 76 32.1% 
47.0 
(28-63) 
20.0  
(4-35) 
15.0*  
(3-31) 
4.5*  
(1-5) 
46 40 82* 
# 1=low, 5=excellent ; * data of one participant missing 
 
1 Ghana, Namibia, Nigeria, South Africa 
2 Bahrain, Iran, Morocco, Pakistan  
3 Belgium, Bulgaria, Denmark, France, Finland, Germany, Greece, Ireland, Italy, Malta, The Netherlands, Poland,   
   Russia, Serbia and Montenegro, Slovakia, Slovenia, Sweden, Turkey, United Kingdom 
4 Argentina, Barbados, Brazil, Mexico, USA 
5 Bangladesh, India, Indonesia, Nepal, Thailand, Vietnam 
6 Australia, China, Japan, Republic of Korea, Taiwan 
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Figure 5: Attrition of participants between the Delphi rounds 
 
 
 
5.3  Linking of the responses to the ICF 
 
Two-hundred and twelve ICF categories were linked to the participants’ 
responses and all components of the ICF were represented (see table 3-7). To 
the component Body Functions 34 second-level categories, 51 third-level 
categories and five fourth-level categories were linked. Fifteen second-level 
categories, 24 third-level categories and two fourth-level categories were 
linked to the component Body Structures. Sixteen second-level categories and 
12 third-level categories were linked to the component Activities and 
Participation. Twenty eight second-level categories and 25 third-level 
categories were linked to the component Environmental Factors. Fifteen 
responses were assigned to the not-yet-developed component Personal 
Factors exclusive the 30 different health conditions. Eleven responses were 
not classified by the ICF. The Kappa statistics for the linking was 0.69 with a 
95% bootstrapped confidence interval of 0.66 – 0.72.  
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Table 3: Representation of identified ICF categories in the Comprehensive ICF Core 
Set for diabetes mellitus: summary of results 
 
  
Body 
Functions 
 
 
Body 
Structures 
 
Activities & 
Participation 
 
Environmental 
Factors 
 
Total 
 
Number of categories identified 
     
- second level 34 15 16 28 93 
- third level 51 24 12 25 112 
- fourth level 5 2 - - 7 
 
Total number of categories identified 
 
90 
 
41 
 
28 
 
53 
 
212 
 
n (%) of categories included in the ICF 
Core Set at the same level of 
classification 
 
26 
(28.8%) 
 
15 
(36.6%) 
 
11 
(39.3%) 
 
20 
(37.7%) 
 
72 
(34.0%) 
 
n (%) of categories included in the ICF 
Core Set at a different level of 
classification 
 
42 
(46.7%) 
 
9 
(22.0%) 
 
4 
(14.3%) 
 
16 
(30.2%) 
 
71 
(33.5%) 
 
n (%) of categories not  included in the 
ICF Core Set with agreement <75% 
 
11 
(12.2%) 
 
6 
(14.6%) 
 
13 
(46.4%) 
 
17 
(32.1%) 
 
47 
(22.2%) 
 
n (%) of categories not included in the 
ICF Core Set with agreement ≥75% 
 
11 
(12.2%) 
 
11 
(26.8%) 
 
0 
(0%) 
 
0 
(0%) 
 
22 
(10.4%) 
 
 
The use of a more detailed ICF category (e.g. b1301 Motivation) implies 
that the less detailed (lower-level) ICF category (e.g. b130 Energy and drive 
functions) is applicable.  
 
 
5.4  Representation of the physicians’ responses in the Comprehensive  
 ICF Core Set for DM 
 
5.4.1  Body Functions 
 
Body Functions was considered the most important area in which 
patients experienced limitations, because 90 categories were linked to it. 
Twenty six ICF categories linked to the participants’ responses are 
34 
 
represented in the Comprehensive ICF Core Set for DM at the same level of 
classification (see table 4). Several responses by the participants were linked 
to the more detailed, higher third-level ICF category, namely b1100 State of 
consciousness, b1301 Motivation, b1303 Craving, b6600 Functions related to 
fertility, b6601 Functions related to pregnancy and b6602 Functions related to 
childbirth, which are represented in the Core Set for DM by the second-level 
categories b110 Consciousness functions, b130 Energy and drive functions 
and b660 Procreation functions, respectively. However, there are six ICF 
categories that are included in the Core Set which could not be linked to the 
data provided by the study population: b1300 Energy level, b1302 Appetite, 
b140 Attention functions, b260 Proprioceptive function, b4551 Aerobic 
capacity, b630 Sensations associated with urinary functions. 
Furthermore, 22 of the participants’ categories were not represented by 
the Comprehensive ICF Core Set for DM. Among these, 11 ICF categories are 
not even represented by a different level category, although at least 75% of the 
participants’ answers have considered them as important. Strictly speaking 
these are b2401 Dizziness, categories covering functions related to the 
digestive system (b5106 Regurgitation and vomiting, b525 Defecation 
functions, b5251 Faecal consistency, b5252 Frequency of defecation, b5253 
Faecal continence, b535 Sensations associated with the digestive system, 
b5350 Sensation of nausea), categories concerning genital and reproductive 
functions (b650 Menstruation functions, b6700 Discomfort associated with 
sexual intercourse) and b830 Other functions of the skin as a category due to 
functions of the skin. The further 11 categories which were not represented by 
the Comprehensive ICF Core Set for DM reached an agreement among the 
participants from 40.0 % to 72.0 %.  
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Table 4: ICF component Body Functions: ICF categories included in the ICF 
Comprehensive Core Set (boldface letters) and ICF categories linked to participants’ 
responses, but not included in the ICF Comprehensive Core Set (lightface letters). 
Percentage of participants who considered the respective ICF category as relevant in 
the last round.  
 
ICF Code ICF Category 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
  
 
 
b110   Consciousness functions  
  b1100  State of consciousness 98.7% 
 b130   Energy and drive functions  
  b1300  Energy level  
  b1301  Motivation 86.8% 
  b1302  Appetite  
  b1303  Craving 68.4% 
 b134   Sleep functions 82.9% 
 b140   Attention functions  
 b152   Emotional functions 88.0% 
  b1522  Range of emotion 88.2% 
 b210   Seeing functions 86.7% 
  b2100  Visual acuity functions 97.4% 
  b2102  Quality of vision 94.7% 
   b21023 Visual picture quality 85.1% 
 b230   Hearing functions 62.7% 
  b2401  Dizziness 92.0% 
 b260   Proprioceptive function  
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ICF Code ICF Category 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
  
 b265   Touch function 97.3% 
 b270   
Sensory functions related to 
temperature and other stimuli 
98.7% 
  b2702  Sensitivity to pressure 94.7% 
  b2703  Sensitivity to a noxious stimulus 98.7% 
 b280   Sensation of pain 97.3% 
   b28011 Pain in chest 92.0% 
   b28014 Pain in upper limb 88.0% 
   b28015 Pain in lower limb 100% 
   b28016 Pain in joints 73.3% 
 b410   Heart functions 94.7% 
  b4101  Heart rhythm 85.3% 
  b4103  Blood supply to the heart 93.3% 
 b415   Blood vessel functions 97.3% 
  b4150  Functions of arteries 100% 
  b4151  Functions of capillaries 93.1% 
  b4152  Functions of veins 68.0% 
 b420   Blood pressure functions 96.0% 
  b4200  Increased blood pressure 98.7% 
  b4201  Decreased blood pressure 88.0% 
  b4202  Maintenance of blood pressure 98.7% 
 b430   Haematological system functions 77.3% 
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ICF Code ICF Category 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
  
  b4300  Production of blood 58.1% 
  b4302  
Metabolite-carrying functions of the 
blood 
64.0% 
  b4303  Clotting functions 73.3% 
 b435   Immunological system functions 94.7% 
  b4350  Immune response 94.7% 
 b440   Respiration functions 66.7% 
 b455   Exercise tolerance functions  
  b4550  General physical endurance 92.0% 
  b4551  Aerobic capacity  
  b4552  Fatiguability 90.5% 
  b5104  Salivation 65.3% 
  b5105  Swallowing 68.9% 
  b5106  Regurgitation and vomiting 82.7% 
 b515   Digestive functions 90.7% 
  b5150  
Transport of food through stomach 
and intestines 
94.7% 
  b5151  Breakdown of food 60.0% 
  b5153  Tolerance to food 57.3% 
 b525   Defecation functions 89.3% 
  b5251  Faecal consistency 76.0% 
  b5252  Frequency of defecation 85.3% 
  b5253  Faecal continence 77.0% 
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ICF Code ICF Category 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
  
 b530   Weight maintenance functions 93.3% 
 b535   
Sensations associated with the 
digestive system 
81.3% 
  b5350  Sensation of nausea 82.7% 
 b540   General metabolic functions 98.7% 
  b5401  Carbohydrate metabolism 97.3% 
  b5403  Fat metabolism 95.9% 
 b545   
Water, mineral and electrolyte 
balance functions 
93.3% 
  b5450  Water balance 86.7% 
  b5451  Mineral balance 81.1% 
 b555   Endocrine gland functions 95.9% 
 b610   Urinary excretory functions 92.0% 
  b6100  Filtration of urine 96.0% 
 b620   Urination functions 96.0% 
  b6201  Frequency of urination 97.3% 
  b6202  Urinary continence 90.7% 
 b630   
Sensations associated with 
urinary functions 
 
 b640   Sexual functions 97.3% 
  b6400  Functions of sexual arousal phase 78.7% 
  b6401  
Functions of sexual preparatory 
phase 
86.5% 
 b650   Menstruation functions 77.0% 
 b660   Procreation functions  
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ICF Code ICF Category 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
  
  b6600  Functions related to fertility 72.6% 
  b6601  Functions related to pregnancy 94.7% 
  b6602  Functions related to childbirth 89.3% 
  b6700  
Discomfort associated with sexual 
intercourse 
84.0% 
 b710   Mobility of joint functions 73.3% 
  b7100  Mobility of a single joint 73.3% 
  b7102  Mobility of joints generalized 62.7% 
  b7200  Mobility of scapula 48.0% 
 b730   Muscle power functions 66.7% 
 b740   Muscle endurance functions 65.3% 
 b770   Gait pattern functions 72.0% 
  b7800  Sensation of muscle stiffness 64.0% 
  b7801  Sensation of muscle spasm 58.7% 
 b810   Protective functions of the skin 88.0% 
 b820   Repair functions of the skin 93.3% 
 b830   Other functions of the skin 81.3% 
 b840   Sensation related to the skin 96.0% 
 b850   Functions of hair 40.0% 
 b860   Functions of nails 70.7% 
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5.4.2  Body Structures 
 
Fifteen categories of the component Body Structures of the current 
Comprehensive ICF Core Set for DM were represented in the participants’ 
responses at the same level of classification (see table 5). The category s630 
Structure of reproductive system is represented in the Core Set by the 
corresponding fourth-level category s63033 Vaginal canal and the third-level 
category s6306 Prostate. Therefore all categories of Body Structures in the 
Comprehensive ICF Core Set for DM are covered by the responses of the 
participants. Nevertheless, there are 11 ICF categories, which are not 
represented in the Core Set, showing an agreement beyond 75% among the 
participants. Two categories covering structures involved in voice and speech 
(s3200, s3301), one category addressing structures of respiratory system 
(s430), four categories concerning structures related to the digestive, 
metabolic and endocrine systems (s5400, s5401, s560, s5801) and another 
four categories covering structures related to movement (s73021, s7700, 
s7701, s7702). Another six categories (s320, s530, s720, s7201, s730, s7302) 
were considered to be important by 58.1% to 71.6% of the participants 
although they are not yet part of the Core Set.  
 
 
5.4.3  Activities and Participation 
 
Eleven categories of the component Activities and Participation could be 
linked to the participants’ responses at the same level of classification (see 
Table 6). These in the Comprehensive ICF Core Set included categories are 
d440, d475, d570, d620, d750, d760, d770, d845, d850, d920. However, there 
are seven ICF categories that are included in the Comprehensive ICF Core 
Set for DM which could not be linked to the data provided by the study 
population. The second-level category d920 recreation and leisure is covered 
in the Core Set by the responses as well and represents as a less-detailed 
category the non-responded categories d9204 hobbies and d9205 socializing, 
which are also part of the given Comprehensive ICF Core Set. Furthermore, 
13 categories (d1551, d230, d2301, d2302, d6505, d660, d820, d840, d855, 
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d8700, d910, d9100, d9101) that were addressed by the participants’ 
responses are not represented in the current Comprehensive ICF Core Set for 
DM, however none of them reached an agreement of 75% or higher. The 
range of agreement was between 23.7% and 60.0%. 
 
 
Table 5: ICF component Body Structures: ICF categories included in the ICF 
Comprehensive Core Set (boldface letters) and ICF categories linked to participants’ 
responses, but not included in the ICF Comprehensive Core Set (lightface letters). 
Percentage of participants who considered the respective ICF category as relevant in 
the last round.  
 
ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
 s140   
Structure of sympathetic 
nervous system 
89.3% 
 s150   
Structure of 
parasympathetic nervous 
system 
88.0% 
 s220   Structure of eyeball 69.9% 
  s2203  Retina 97.3% 
  s2204  Lens of eyeball 98.7% 
 s320   Structure of mouth 64.4% 
  s3200  Teeth 94.7% 
  s3301  Oral pharynx 76.0% 
 s410   
Structure of cardiovascular 
system 
94.7% 
  s4100  Heart 98.7% 
  s4101  Arteries 98.7% 
  s4102  Veins 85.3% 
  s4103  Capillaries 93.3% 
 s430   
Structure of respiratory 
system 
77.3% 
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ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
 s530   Structure of stomach 67.6% 
  s5400  Small intestine 80.0% 
  s5401  Large intestine 80.0% 
 s550   Structure of pancreas 84.0% 
 s560   Structure of liver 86.7% 
  s5801  Thyroid gland 89.3% 
 s610   Structure of urinary system 88.0% 
  s6100  Kidneys 97.3% 
  s6102  Urinary bladder 94.7% 
 s630   
Structure of reproductive 
system 
 
   s63033 Vaginal canal 78.4% 
  s6306  Prostate 65.3% 
 s720   Structure of shoulder region 58.1% 
  s7201  Joints of shoulder region 62.7% 
 s730   Structure of upper extremity 58.1% 
  s7302  Structure of hand 71.6% 
   s73021 Joints of hand and fingers 77.3% 
 s750   Structure of lower extremity 80.0% 
  s7500  Structure of thigh 68.0% 
  s7501  Structure of lower leg 82.7% 
  s7502  Structure of ankle and foot 96.0% 
  s7700  Bones 82.7% 
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ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
  s7701  Joints 80.0% 
  s7702  Muscles 86.7% 
 s810   Structure of areas of skin 92.0% 
  s8102  Skin of upper extremity 77.3% 
  s8104  Skin of lower extremity 96.0% 
 s830   Structure of nails 91.8% 
 
 
Table 6: ICF component Activities and Participation: ICF categories included in the 
ICF Comprehensive Core Set (boldface letters) and ICF categories linked to 
participants’ responses, but not included in the ICF Comprehensive Core Set 
(lightface letters). Percentage of participants who considered the respective ICF 
category as relevant in the last round.  
 
 
ICF Code 
 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
  d1551  Acquiring complex skills 50.7% 
 d230   Carrying out daily routine 56.0% 
  d2301  Managing daily routine 56.0% 
  d2302  Completing the daily routine 60.0% 
 d240   
Handling stress and other 
psychological demands 
 
 d440   Fine hand use 59.5% 
 d450   Walking  
 d455   Moving around  
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ICF Code 
 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
 d475   Driving 58.7% 
  d4751  Driving motorized vehicles 53.3% 
 d520   Caring for body parts  
 d570   Looking after one’s health 85.1% 
  d5701  Managing diet and fitness 91.8% 
  d5702  Maintaining one's health 88.0% 
 d620   
Acquisition of goods and 
services 
41.3% 
 d630   Preparing meals  
  d6505  
Taking care of plants, indoors 
and outdoors 
23.7% 
 d660   Assisting others 36.8% 
 d750   Informal social relationships 39.5% 
 d760   Family relationships 59.2% 
 d770   Intimate relationships 68.4% 
 d820   School education 56.0% 
 d840   
Apprenticeship (work 
preparation) 
44.7% 
 d845   
Acquiring, keeping and 
terminating a job 
61.8% 
  d8450  Seeking employment 48.7% 
 d850   Remunerative employment 48.0% 
 d855   non-remunerative employment 28.9% 
  d8700  Personal economic resources 42.1% 
 d910   Community life 40.8% 
  d9100  Informal associations 40.8% 
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ICF Code 
 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
  d9101  Formal associations 35.5% 
 d920   Recreation and leisure 67.1% 
  d9201  Sports 77.6% 
  d9204  Hobbies  
  d9205  Socializing  
 
 
5.4.4  Environmental Factors 
 
Twenty categories of the component Environmental Factors were linked 
to participants’ responses. They are included in the Comprehensive ICF Core 
Set for DM at the same level of classification (see table 7). The responses and 
categories e110 Products or substances for personal consumption, e550 Legal 
services, systems and policies, e590 Labour and employment services, 
systems and policies, e595 Political services, systems and policies were linked 
to the more detailed, third-level ICF category. This is shown by e1100 Food 
and e1101 Drugs which are represented in the Comprehensive ICF Core Set 
for DM by the corresponding second-level category e110 Products or 
substances for personal consumption, respectively. Moreover, there are five 
ICF categories that are included in the Core Set which could not be linked to 
the data provided by the study population. Although 17 further categories were 
identified by the participants’ responses which are not included in the 
Comprehensive ICF Core Set for DM (e120, e1250, e130, e1300, e1650, 
e2151, e2250, e2255, e230, e335, e460, e530, e5350, e540, e5401, e565, 
e5650) the range of agreement was between 30.3% and 64.5 %. None of 
these categories reached a significant agreement of more than 75%. 
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5.4.5  Personal Factors 
 
The Personal Factors are related to the patients’ way of dealing with 
their condition, like knowledge about the disease, compliance and coping 
strategies as well as healthy lifestyle and self management including the 
understanding of therapeutic strategies. Fifteen answers were linked to this 
not-yet-developed ICF component (see table 8). The participants agreed on 
the importance of all mentioned Personal Factors by a percentage between 
82.7 % and 98.7%. Additionally the Personal Factors include other health 
conditions as well (Geyh et al, 2011). The thirty responses regarding these 
health conditions are separately listed in Table 9. 
 
 
Table 7: ICF component Environmental Factors: ICF categories included in the ICF 
Comprehensive Core Set (boldface letters) and ICF categories linked to participants’ 
responses, but not included in the ICF Comprehensive Core Set (lightface letters). 
Percentage of participants who considered the respective ICF category as relevant in 
the last round.  
 
ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
 e110   
Products or substances for 
personal consumption 
 
  e1100  Food 90.8% 
  e1101  Drugs 90.8% 
 e115   
Products and technology for 
personal use in daily living 
55.3% 
  e1150  
General products and technology 
for personal use in daily living 
49.3% 
  e1151  
Assistive products and technology 
for personal use in daily living 
68.9% 
 e120   
Products and technology for 
personal indoor and outdoor 
mobility and transportation 
56.0% 
  e1250  
General products and technology 
for communication 
50.7% 
 e130   
Products and technology for 
education 
48.7% 
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ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
  e1300  
General products and technology 
for education 
51.3% 
  e1650  Financial assets 30.3% 
  e2151  Population density 30.3% 
  e2250  Temperature 46.1% 
  e2255  Seasonal variation 47.4% 
 e230   natural events 38.2% 
 e310   Immediate family 69.7% 
 e315   Extended family 53.9% 
 e320   Friends  
 e325   
Acquaintances, peers, 
colleagues, neighbours and 
community members 
53.9% 
 e330   People in positions of authority 52.6% 
 e335   People in subordinate positions 36.8% 
 e340   
Personal care providers and 
personal assistants 
64.0% 
 e355   Health professionals 89.3% 
 e360   Other professionals 51.3% 
 e410   
Individual attitudes of immediate 
family members 
71.1% 
 e415   
Individual attitudes of extended 
family members 
55.3% 
 e420   Individual attitudes of friends 63.2% 
 e425   
Individual attitudes of 
acquaintances, peers, 
colleagues, neighbours and 
community members 
59.2% 
 e430   
Individual attitudes of people in 
positions of authority 
 
48 
 
ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
 e440   
Individual attitudes of personal 
care providers and personal 
assistants 
 
 e450   
Individual attitudes of health 
professionals 
73.7% 
 e455   
Individual attitudes of other 
professionals  
 
 e460   Societal attitudes 64.5% 
 e465   
Social norms, practices and 
ideologies 
60.5% 
 e510   
Services for the production of 
consumer goods 
 
 e530   
Utilities services, systems and 
policies 
32.0% 
  e5350  Communication services 40.0% 
 e540   
Transportation services, systems 
and policies 
33.3% 
  e5401  Transportation systems 58.7% 
 e550   
Legal services, systems and 
policies 
 
  e5500  Legal services 32.0% 
 e555   
Associations and organizational 
services, systems and policies 
40.0% 
  e5550  
Associations and organizational 
services 
49.3% 
  e5552  
Associations and organizational 
policies 
49.3% 
 e560   
Media services, systems and 
policies 
48.0% 
  e5600  Media services 64.0% 
 e565   
Economic services, systems and 
policies 
38.7% 
  e5650  Economic services 40.0% 
 e570   
Social security services, systems 
and policies 
61.3% 
  e5700  Social security services 71.6% 
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ICF Code 
 
ICF Category 
 
% Agreement in 
final round 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
  
  e5701  Social security systems 61.6% 
 e575   
General social support services, 
systems and policies 
65.3% 
  e5750  General social support services 67.6% 
 e580   
Health services, systems and 
policies 
92.0% 
  e5800  Health services 94.6% 
  e5801  Health systems 88.9% 
  e5802  Health policies 85.1% 
 e585   
Education and training services, 
systems and policies 
68.5% 
 e590   
Labour and employment 
services, systems and policies 
 
  e5900  Labour and employment services 50.0% 
 e595   
Political services, systems and 
policies 
 
  e5951  Political systems 39.2% 
 
 
Table 8: ICF component Personal Factors: Percentage of participants who considered 
the respective response as relevant in the third round. 
 
Answer 
 
Personal Factors 
% Agreement in 
final round 
Comorbidities 98.7% 
Compliance 98.7% 
Conviction 82.7% 
Coping 93.3% 
Health literacy 93.3% 
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Answer 
 
Personal Factors 
% Agreement in 
final round 
Healthy lifestyle 98.7% 
Heritability of diabetes 92.0% 
Knowledge about disease 98.7% 
Lack of self-confidence 97.3% 
Patient education about disease 98.7% 
Self empowerment 93.3% 
Self management 98.7% 
Self-decision making 94.7% 
Understanding of therapeutic strategies 98.7% 
Loss of liberty 86.7% 
 
 
Table 9 Health conditions: Percentage of participants who considered the respective 
response as relevant in the third round 
 
Answer 
 
Health conditions 
% Agreement in 
final round 
Abscess 
98.6% 
Anaemia 
91.9% 
Arthritis 
80.0% 
Cardiovascular diseases 
100% 
Carpal tunnel syndrome 
94.7% 
Cataract 
97.3% 
Cerebrovascular disease 
100% 
Coeliac disease 
80.0% 
Depression 
100% 
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Answer 
 
Health conditions 
% Agreement in 
final round 
Diabetes neuropathy 
100% 
Diabetic foot 
100% 
Diverticulitis 
53.3% 
Endocrine disorders 
98.7% 
Gestational diabetes 
98.7% 
Gout 
87.8% 
Intercurrent pneumonia 
93.3% 
Nephropathy 
100% 
Obesity 
100% 
Osteomyelitis 
93.3% 
Osteoporosis 
88.0% 
Peripheral vascular disease 
100% 
Pregnancy 
94.7% 
Pulmonary TBC infection 
82.7% 
Renal hypertension 
93.3% 
Retinopathy 
97.3% 
Scleroedema of skin 
66.7% 
Sepsis 
97.3% 
Sleep apnea 
89.3% 
Type 1 Diabetes 
100% 
Type 2 Diabetes 
100% 
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5.4.6  Not classified 
 
Eleven responses of the participants including aggravation of diabetes, 
diabetic research, insulin resistance and screening for relatives were declared 
“not covered by the ICF” (see Table 10). However, the answer neuropathy 
problems reached an agreement of 100%. 
 
 
Table 10: Responses that could not be linked to a specific ICF category since the 
concept is not classified by ICF. Percentage of participants who considered the 
respective responses as relevant in the last round. 
 
Answer 
 
Not classified 
% Agreement in 
final round 
Aggravation of diabetes 97.3% 
Antibiotic resistance 78.4% 
Dealing with the complex medicines and eating dosage regimen 98.6% 
Diabetic research 93.2% 
Exercise opportunity 95.9% 
Insulin resistance 97.3% 
Lack of communication between patient and physician 97.3% 
Neuropathy problems 100% 
Patients are always on the lookout for the proverbial 'cure' 97.8% 
Screening for relatives 93.2% 
Swelling in their joints 70.3% 
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6  Discussion 
 
Overall the different components of the current version of the 
Comprehensive ICF Core Set for DM namely Body Functions, Body 
Structures, Activities and Participation and the Environmental Factors were 
almost completely represented by the participants’ responses in this validation 
study. The responses of the participants of this study confirmed 67.5% of the 
already included categories at the same or at a different level. Of the 
components Activities and Participation and Environmental Factors no 
categories were identified by the participants which had an agreement of at 
least 75%, but are not included in the current version of the Comprehensive 
ICF Core Set for DM. However, 22 categories of the components Body 
Functions and Body Structures were found which are not included in the ICF 
Core Set and were rated as important by at least 75% of the participants. 
These categories indicate a lack of validity from the perspective of physicians 
and will be discussed in the following section. 
 
 
6.1  Body Functions 
 
More than 90% of the participants agreed that the ICF category b2401 
Dizziness represents an important aspect, although this category is not 
included in the ICF Core Sets for DM. Dizziness describes a variety of 
sensations that limit the patients’ daily activities. Possible reasons for the 
inability to maintain the sense of balance can be a manifestation of dysfunction 
of the neurologic, cardiovascular, psychiatric, or vestibular systems (Chan, 
2009). Dizziness is a familiar symptom of diabetic complications, such as 
hypoglycaemia e.g. due to overdosed insulin injection (Hepburn et al, 1991), 
diabetic ketoacidosis (DKA) and hyperosmolar hyperglycaemic syndrome 
(HHS) (ADA, 2001; Kitabchi, 2001). Furthermore, complications like reduced 
cardiovascular autonomic function based on diabetic neuropathy, in particular 
autonomic neuropathy (Vinik et al, 2003), acute coronary syndrome (DeVon et 
al, 2008) and stroke (Mohr, 2004) can go along with dizziness. Actually 
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dizziness is a nonspecific, subjective and commonly treated symptom but it is 
not to be underestimated as a medical condition in patients with DM. 
A sizeable number of publications support a relationship between DM 
and upper and lower gastrointestinal symptoms. Almost 75% of patients 
(Chandrasekharan et Srinivasan, 2007) with DM have symptoms like delayed 
gastric emptying, vomiting, nausea, bloating, heartburn, abdominal pain, 
dysphagia, diarrhea with watery stool interchanging with constipation and fecal 
incontinence due to a weak sphincter tone. Especially motility disorders like 
gastroparesis are common problems. This dysfunction of the gastrointestinal 
system in case of DM is caused mainly by great fluctuations in blood glucose, 
the presence of irreversible autonomic neuropathy with alteration in neuron 
number and size and coexisting psychiatric illnesses (Bytzer et al, 2001; 
Chandrasekharan et Srinivasan, 2007; Vinik et al, 2003). Due to these facts it 
is not surprising that the experts in this survey support the ICF categories 
b5106 Regurgitation and vomiting, b525 Defecation functions and the more 
detailed categories b5251 (Faecal consistency), b5252 (Frequency of 
defecation), b5253 (Faecal continence) although these categories are not 
included in the Comprehensive ICF Core Set for DM.  
Additionally the categories b535 Sensations associated with the 
digestive system and the more detailed one b5350 Sensation of nausea as 
well as the body structure categories s5400 Small instestine and s5401 Large 
instestine were rated as important with over 80% acceptance. In the study 
from the perspective of the patients of Kirchberger et al 2009 the category 
b525 Defecation functions was also endorsed. This intensifies the potential 
need of including this category to the ICF Core Sets.  
The management of DM is partly gender specific, above all in items due 
to genital and reproductive functions. In reference to that, the ICF category 
b650 Menstruation functions was considered to be relevant in the treatment of 
DM by the participants. Many studies confirmed that type 1 diabetes in young 
women is associated with menstrual irregularities like later menarche, oligo- 
and amenorrhea or long cycles and heavy menstruation (Strotmeyer et al, 
2003). The cause of these disorders could be located in an uncontrolled DM 
induced dysfunction of the hypothalamic-pituitary-gonadal axis (Griffin et al, 
1994). Menstrual cycle disturbances in older women with type 2 diabetes have 
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not been well examined in contrast to type 1 diabetes in young adults. They 
are related basically to problems concerning menopause. Nevertheless it 
should be mentioned that women with unbalanced menses have an enlarged 
risk for type 2 diabetes (Solomon et al, 2001), especially women of 
childbearing potential with the endocrine disorder Polycystic Ovary Syndrome 
(PCOS) have this risk factor. PCOS could follow from insulin resistance and 
hyperinsulinaemia. More than 5% of the women with this syndrome have 
manifest DM. Furthermore, the physiological decrease of hormones in 
menopause could affect the well adjusted blood glucose level. Premenopausal 
diabetic women often have to adjust the management of DM, because the 
modification of the hormone status induces a reduced need for insulin and 
hence hypoglycaemia. Due to the similar symptoms of menopause and low 
blood sugar, e.g. hot flushes, it is necessary to measure the blood-glucose 
level at frequent intervals and to intensify the support by physicians. A 
hormonal replacement therapy could as well be beneficial, because the insulin 
demand turns to premenopausal levels and the risk of developing heart 
disease abates (Jovanovic, 2004).  
Moreover, 84% of the experts in this survey named the ICF category 
b6700 Discomfort associated with sexual intercourse. Sexual dysfunction for 
men and women is quite common in DM and is mainly caused by vascular and 
neuropathic failure. Endocrine changes are responsible for mood swings, 
reduced libido and sexual arousal. The typical problems of men, e.g. erectile 
dysfunction, are mainly caused by vascular and neuropathic failure. The 
reduced libido and mood swings are consequences of a lower level of the 
hormone testosterone (Hijazi, 2004). The female sexual dysfunction is also 
induced by neuropathic vascular complications and endocrine changes. 
Characteristic symptoms are reduced sexual arousal and lack of sexual desire. 
Furthermore, the disturbed vaginal lubrication and sensitivity provokes 
dyspareunia and discomfort during the intercourse (Fatemi et Taghavi, 2009). 
The diabetic autonomic neuropathy comprises multiple symptoms and 
impairments in a variety of organs. For instance the sudomotor function of the 
skin is affected. A reduced sympathetic skin response as for example lower 
sweat secretion up to anhidosis, heat intolerance and dry skin generates 
fissures and leaks in the skin. Thus, the infection risk with pathogenetic agents 
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is increased (Vinik et al, 2003, Asahina et al, 2008). Moreover, a rare symptom 
of diabetic neuropathy due to sudomotor function is the phenomenon of 
gustatory sweating. This excessively sweating around head and neck during or 
after food intake (Blair et al, 2002) can be traced back to a reinnervated nerve 
function within the autonomous nerve system. In reference to these 
constrictions the participants deemed the not yet included ICF category b830 
Other functions of the skin to be important, as well as the patients’ themselves 
in the study of Kirchberger et al 2009.  
 
 
6.2  Body Structures 
 
Many of the patients’ problems treated by physicians are represented by 
categories assigned to the component Body Structures. These are the 
anatomical parts of the body such as organs or limbs and the participants were 
asked about impairments like deviation, qualitative changes in structure or 
loss. 
The ICF categories s3200 Teeth and s3301 Oral pharynx belonging to 
the component Body Structures were supported by the experts in DM but they 
are not included in the ICF Core Sets for DM. According to literature 
(Skamagas et al, 2008), perioral diseases like acute infections with bacteria or 
candida are increased in diabetic patients. The oral and oropharyngeal 
symptomatology includes acute infections with bacteria, candida and other 
opportunistic pathogenetic microorganisms. Uncontrolled inflammation, tooth 
loss and tissue destruction up to necrosis are the result of e.g. peridontitis. 
Furthermore, DM is a risk factor for possible precancerous lesions and 
malignant oral neoplasm. To control these implications the oral hygiene has to 
be improved.  
The ICF category s430 Structure of respiratory system includes, on a 
more detailed level, the trachea, the lungs, the thoracic cage and the muscles 
of respiratory system. The participants rated this category to be a relevant 
structure affected by DM. A number of publications have controversial attitudes 
towards the question, whether the lung is a target to DM or not. Some studies 
could show a diabetic microangiopathy in the lungs for example a thickened 
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epithelial and capillary basal membrane, hyalinosis of vessels and insudation 
(Kodolova et al, 1982). However, in situations such as aging, smoking or 
primary lung diseases the subclinical dysfunction of the diabetic lung could 
become significant (Kaparianos et al, 2008). Commonly, diabetic patients have 
an increased risk of acquiring infections, such as pulmonary fungal diseases, 
tuberculosis and other opportunistic pathogens. These infections may lead to 
inflammation with tissue destruction or invasion in vascular structures (Marvisi 
et al, 1996). Furthermore, it has to be mentioned that the inhalable insulin as a 
noninvasive medication option makes only small modifications in lung function 
and lesions in structures are not associated (Strack, 2006). 
Some other ICF categories not included in the ICF Core Sets for DM but 
regarded as relevant by the participants are s5400 Small intestine and s5401 
Large intestine. The dysfunction in intestinal motility is caused by structure 
damaging of the enteric nervous system described as neurodegenerative 
processes. Axonal swelling, alteration in neuron number and size, varied 
expressed neurotransmitters and nerve-immune interactions generate the 
motility related problems. In addition, there are multiple triggers like poor 
glycaemic control, psychiatric disorders and other metabolic derangements 
deduced by DM (Bytzer et al, 2001; Chandrasekharan et Srinivasan, 2007).  
A further category identified in this survey by the experts that is not 
included in the Comprehensive ICF Core Set for DM is s560 Structure of liver. 
In diabetic patients almost 70% have liver function disturbances like Non-
Alcoholic Fatty Liver Disease (NAFLD). Insulin resistance, Hyperinsulinaemia, 
intensified oxidative stress to the hepatocytes and other comorbidities like 
obesity and hypertriglyceridaemia are associated. The inoffensive form of 
NAFLD shows an accumulation of fat with no significant liver destruction. A 
progression of NAFLD with specific inflammation changes and fibrosis could 
lead to Non-Alcoholic Steatohepatitis (NASH) with hepatocellular necrosis and 
to severe liver damage such as cryptogenic cirrhosis and hepatocellular 
carcinoma. To prevent diabetic patients with NAFLD or NASH from 
aggravation and early mortality an efficient diagnosis, optionally by liver 
biopsy, lifestyle intervention and a controlled carbohydrate metabolism is 
indicated (Cusi, 2009; Podolsky, 2004; Yu et Keeffe, 2002). Additionally there 
is an independent and less recognized complication of long lasting 
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hyperglycaemia named glycogenic hepatopathy (GN), which mostly occurs in 
patients with type 1 diabetes (Torbenson et al, 2006). It is characterized by 
elevated liver enzymes, glycogen accumulation in swollen hepatocytes and 
hepatomegaly.  
Although type 1 diabetes has only a prevalence of about 5%, it seems 
as if the physicians that participated in this study still treat many patients with 
type 1 diabetes. This is most likely the reason why the experts rated the ICF 
category s5801 Thyroid gland with 89.3% as an important structure which is 
affected by DM and which has to be included in the Comprehensive ICF Sore 
Set for DM. Thyroid diseases, in particular induced by autoimmune 
dysregulations, are frequent in patients with type 1 diabetes (Hansen et al, 
1999). The relationship between patients with type 2 diabetes and thyroid 
diseases is not well documented in literature. About 15% of patients with DM 
have thyroid affections which are mainly caused by immunological and genetic 
factors. The chronic autoimmune thyroiditis is most commonly and mainly 
caused by immunological and genetic factors. Clinical signs are e.g. 
hypothyroidism and goiter (Schroner et al, 2008; Dayan et Daniels, 1996).  
DM is also associated with several musculoskeletal disorders of the 
hand and fingers. The ICF category s73021 Joint of hand and fingers was 
considered as relevant by the participating experts. That explains the 
occurrence of the corresponding category s73021 Joint of hand and fingers 
because amongst diabetic patients impairments such as Limited joint mobility 
(LJM), Dupuytren’s disease (DD), Carpal tunnel syndrome (CTS) and 
stenosing tendosynovitis (trigger finger) have an increased incidence 
compared to the general population. Due to connective tissue changes, 
neuropathy and vasculopathy, these impairments are leading to increased 
stiffness, palpable palmar and digital nodules, contractures and thickening of 
ligaments and peritendinousus tissue (Fitzgibbons et Weiss, 2008). The ICF 
category s7701 Joints, which is also not yet included in the ICF Core Sets for 
DM, but was regarded as important by the experts addresses similar contents. 
In particular the small joints of the hands are involved resulting in a 
cheiroarthropathy, frozen shoulder, Dupuytren’s contracture or trigger finger 
(Aljahlan et al 1999; Aydeniz et al 2008). However, the joints in general could 
be affected by long-term DM and they become passively more inflexible. The 
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other way round the syndrome of limited joint mobility affects the joints of 
diabetic feet and increases the risk to ulceration and amputation.  
Furthermore, Diabetic osteoarthropathy, also known as Charcot’s joint, 
is a common complication of DM and compromises joints and bones. It is 
regularly associated to diabetic neuropathy. The joints which are strained by 
weight become progressively destructed and the results are subsequent 
dislocations, fractures, and deformities (Shah et Hugghins, 2002). Thus, not 
least the ICF category s7700 Bones was considered as affected by DM by the 
participants. In addition, diabetic structure alterations in bone quality and 
quantity result in an increased risk of fractures, like in hip and proximal 
humerus. However, there are different causes for fractures in patients with 
type 1 and type 2 diabetes. In patients with type 1 diabetes a reduced bone 
mineral density (BMD) is measured whereas in patients with type 2 diabetes 
the BMD is normal to elevated. Although this seems to be paradox, the bone 
could be impacted in various other ways, including e.g. poor bone quality, 
changes in insulin level, hyperglycaemia with higher concentrations of 
advanced glycation end products in collagen, microangiopathy, inflammation 
or frequent falls due to secondary diseases like diabetic retinopathy, stroke or 
peripheral polyneuropathy with balance disturbances (Schwartz, 2002).  
Although Insulin has an anabolic and strengthening effect to the bone 
architecture, the fracture risk persists in people with hyperinsulinaemic states. 
This supports the assumption that there is a multifactorial genesis of bone 
affection in DM (Thrailkill et al, 2005). 
Finally, the ICF category s7702 Muscles was identified by the 
participating physicians. A study (Park et al, 2009) supports this opinion by 
investigating that type 2 diabetes has a significant influence on excessive loss 
of skeletal muscle mass in older patients. Additionally, impairments and 
atrophy of the skeletal muscle caused by distinct diabetic neuropathy do often 
occur. Muscle weakness is the associated symptom especially at the ankle 
and knee (Andresen, 1999). A rare complication, diabetic myonecrosis, takes a 
special position in muscle structure damage and arises in patients with long-
standing DM with complications like neuropathy, retinopathy or nephropathy. 
The involved muscle is painfully swollen, the muscle strength is decreased and 
sometimes there is a palpable tender mass, consisting of muscle necrosis and 
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edema (Glauser et al, 2008). Furthermore, muscle structure changes in DM 
could also result from diabetic amyotrophy whose pathogenesis is still 
unknown. Microvasculitis and secondary ischaemia of the lumbosacral plexus 
could be the reason (Bhanushali et Muley, 2008). 
Due to the reduced immune system functions of patients with DM 
infectious and inflammatory problems like pyomyositis, abscess, necrotizing 
fasciitis, osteomyelitis, dermatomyositis and polymyostitis could come up with 
severe structure damage as well (Glauser et al, 2008).  
 
 
6.3  Personal Factors 
 
A large number of participants’ responses were identified as Personal 
Factors. According to the ICF language Personal Factors are Contextual 
Factors related to the individual such as age, gender, character style, other 
health conditions, education, and coping styles (WHO, 2001). They are not yet 
classified in the ICF. Final agreements of more than 90% have been reached 
in 35 issues in the study. This finding highlights the importance of Personal 
Factors to the physicians’ treatment of patients with DM.  
In this survey especially other health conditions, coping styles and self 
management were mentioned by the participants. This is not surprising 
considering that DM is a disease which affects the body in multifactorial ways. 
The complications and secondary diseases could be mild, severe or even life-
threatening, if there is no medical care available. 
Patients suffering from DM use a combination of coping strategies and 
the perception of control over DM can be a relevant factor (Macrodimitris et 
Endler, 2001).  
Furthermore, perceived autonomous support from health care providers 
is positively associated with autonomous self-regulation. Perceived 
autonomous support and perceived competence both were clearly associated 
with quality of life, adherence to medications and glycaemic control in diabetic 
patients. Diabetes-related health outcome could be advanced by improving the 
self-management (Williams et al, 2009). However, all mentioned Personal 
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Factors emphasize the need of self-management and regular checkups due to 
the possible severe complications. 
A systematic literature review from Geyh et al (2011) and a qualitative 
approach from Grothkamp (2012) stress this need of development and the 
relevance for Personal Factors in the use of the ICF in clinical, administrative 
and research settings. The implementation of the Personal Factors could be 
various and illustrates the individuals’ attitudes and needs, especially related to 
the variety in different cultural and social positions. The processing of the 
Personal Factors in the ICF could be an approach to get a comprehensive and 
complete description of relevant aspects influencing a patient’s functioning and 
health and to sustain the claim of people with disabilities. In general a 
classification of the Personal Factors would improve the diagnostic and 
therapeutic strategies in patients with DM in each nation.  
 
 
6.4  Not covered 
 
There are some results that are not sufficiently covered by the ICF. The 
role of non-oral drugs in the treatment of patients with DM is a very important 
matter. In type 1 diabetes and in advanced stage of type 2 diabetes it is 
essential for patients to inject or in some cases to inhale Insulin (Nathan et al, 
2009). The ICF category e110 Products or substances for personal 
consumption includes on a more detailed level Drugs in its definition. The 
definition contains the phrase “for ingestion”, which is just related to oral 
medication. At this point a more detailed subcategory on the level like e1101 
Drugs would be helpful und could complete the ICF classification.  
 
Furthermore, the experts named various difficulties in patients with DM 
addressed to the self-management, such as the necessary skills handling 
insulin injections, monitoring the blood glucose level and the management of 
physical activity and diet. The category d570 Looking after one’s health and 
the related, more detailed categories do not fully cover these explicit patients’ 
problems. Also the category d1551 Acquiring complex skills cannot solve the 
problem of a specific category. As Kirchberger et al, 2009 and Awad et al., 
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2009 correctly mentioned the complex problem of self management is not 
covered by a definite ICF category. Depending on these analogue findings the 
implementation of a specific category has to be considered.  
 
The component Body Structures is divided in its first chapter into the 
different structures of the nervous system. In this schedule the categories for 
peripheral nerves are not perfectly represented. Due to the importance of the 
cumulative complications of the diabetic neuropathy and the subsequently 
following problems, it is necessary to include a further category besides s198 
Structures of the nervous system, other specified and s199 Structures of the 
nervous system, unspecified. In particular chronic sensorimotor distal 
polyneuropathy (DPN) is mentioned by burning and stabbing pain or 
paraesthesia of the proximal lower extremities. Although there are different 
theories trying to define the precise cause of the diabetic neuropathy, the 
electrophysiological deficits demonstrates the structure damage of the nerve 
fibers (Chin et Rubin, 2009).  
 
 
 
7  Limitations 
 
 
The reliability of this study is demonstrated by the response rates and 
the inter-rater reliability as assessed with the Kappa statistics and its 95% 
bootstrapped confidence interval. The Kappa statistics for the linking was 0.69 
with a 95% bootstrapped confidence interval of 0.66 – 0.72 and reflects a 
moderate agreement between the health professionals who performed the 
linking. The Kappa coefficient ranges from 0 to 1. The complete agreement 
between two raters, in this case trained health professionals, would result in a 
value of 1. Contrary, a coefficient of 0 represents no additional agreement 
beyond what is expected by chance alone (Vierkant, 2007). The reported 
attrition rates of roughly 50% have been exceeded conspicuously by response 
rates between 81.6% and 96.2% in the single rounds. Therefore, to 
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accomplish the aim of the study the Delphi technique seemed to be an 
adequate method (Geschka, 1977). 
 
The worldwide prevalence of DM is represented in the international 
provenance of the participants from all six world regions. These regions are 
defined by the World Health Organization and the recruitment provides a wide 
spread of expert opinion. Anyhow, the representativeness of this survey results 
and the external validity are restricted, because some world regions such as 
the African region and the Eastern Mediterranean region seem to be 
underrepresented with four participants in the third Delphi round. This fact may 
show a supposable lack of experts in DM in this region. However, the reasons 
of underrepresentation of experts could be various. It is always important to 
consider the infrastructure, the political and social situations in some states 
and therefore the possibility to get access to an email server and other 
multimedia communication systems. Another factor for limited 
representativeness is that there was no random sample of the participants 
available, most likely due to the absence of target population databases. 
Hence, this sample does not represent the full spectrum of the physicians 
experienced in the treatment of DM patients worldwide. Therefore, further 
validation studies should be accomplished to investigate the experience of 
physicians in DM from the underrepresented countries in this study. 
 
 
 
8  Conclusion 
 
 
The requirement for practicability led to the development of the ICF 
Core Sets in order to use them in daily practice. The Comprehensive Core Set 
for DM reflects the entire spectrum of typical problems in patients with DM and 
defines a list of the most relevant ICF categories in relation to the functioning 
in patients with DM. Hence, the definition of “what to measure” and not “how to 
measure” was generated. The use of the ICF Core Sets provides the 
interdisciplinary and comprehensive description of functioning and a common 
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language for health professionals (Stucki et al, 2002). The creation of 
standardized functioning profiles supplies the identification of necessary follow-
up treatment and intervention goals. Furthermore, the use promotes patient-
orientated goal setting and treatment as well as creating assessment 
schedules is facilitated. To find guidance on how to use the ICF Core Sets a 
manual for clinical practice has been created. This useful guideline should help 
the health professionals to structure the clinical description and assessment of 
functioning (Bickenbach et al, 2012). So far 33 ICF Core Sets have been 
developed (ICF Research Branch, 2013 DIMDI 2013), whereas the 
development projects are still ongoing for different other health conditions.  
The validity of the Comprehensive Core Set for DM from the different 
perspectives including the health professionals’ and the patients’ perspective 
was confirmed in this and other different studies. (Rouf et al, 2004; Weigl et al, 
2004; Awad et al, 2009; Kirchberger et al 2009; Abdullah et al, 2011). Further 
modified versions of the Comprehensive Core Set for DM would be important 
to discuss due to progressive changes of understanding, diagnosis and 
treatment of health conditions over time. Particularly a very important aspect of 
functioning would be the interaction between health conditions and the 
contextual factors as Environmental and Personal Factors. Further validation 
research in this area is a direction for future studies. At present the use of the 
ICF and the ICF Core Sets in clinical practice is developing (Bickenbach et al, 
2012). 
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10  Attachements (Anhang) 
 
 
10.1  Comprehensive ICF Core Set for Diabetes Mellitus 
 
Categories of the component Body Functions: 
 
ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
 
 
 
b110   Consciousness functions 
 b130   Energy and drive functions 
  b1300  Energy level 
  b1302  Appetite 
 b134   Sleep functions 
 b140   Attention functions 
 b152   Emotional functions 
 b210   Seeing functions 
 b260   Proprioceptive function 
 b265   Touch function 
 b270   
Sensory functions related to 
temperature and other stimuli 
 b280   Sensation of pain 
 b410   Heart functions 
 b415   Blood vessel functions 
 b420   Blood pressure functions 
 b430   Haematological system functions 
 b435   Immunological system functions 
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ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
 
 b455   Exercise tolerance functions 
  b4550  General physical endurance 
  b4551  Aerobic capacity 
  b4552  Fatiguability 
 b515   Digestive functions 
 b530   Weight maintenance functions 
 b540   General metabolic functions 
 b545   
Water, mineral and electrolyte 
balance functions 
 b555   Endocrine gland functions 
 b610   Urinary excretory functions 
 b620   Urination functions 
 b630   
Sensations associated with 
urinary functions 
 b640   Sexual functions 
 b660   Procreation functions 
 b710   Mobility of joint functions 
 b730   Muscle power functions 
 b810   Protective functions of the skin 
 b820   Repair functions of the skin 
 b840   Sensation related to the skin 
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Categories of the component Body Structures: 
 
ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
 
 s140   
Structure of sympathetic nervous 
system 
 s150   
Structure of parasympathetic 
nervous system 
 s220   Structure of eyeball 
 s410   
Structure of cardiovascular 
system 
  s4100  Heart 
  s4101  Arteries 
  s4102  Veins 
  s4103  Capillaries 
 s550   Structure of pancreas 
 s610   Structure of urinary system 
  s6100  Kidneys 
 s630   Structure of reproductive system 
 s750   Structure of lower extremity 
  s7502  Structure of ankle and foot 
 s810   Structure of areas of skin 
 s830   Structure of nails 
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Categories of the component Activities and Participation: 
 
ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
 
 d240   
Handling stress and other 
psychological demands 
 d440   Fine hand use 
 d450   Walking 
 d455   Moving around 
 d475   Driving 
 d520   Caring for body parts 
 d570   Looking after one’s health 
 d620   
Acquisition of goods and 
services 
 d630   Preparing meals 
 d750   Informal social relationships 
 d760   Family relationships 
 d770   Intimate relationships 
 d845   
Acquiring, keeping and 
terminating a job 
 d850   Remunerative employment 
 d920   Recreation and leisure 
  d9201  Sports 
  d9204  Hobbies 
  d9205  Socializing 
 
 
 
 
 
87 
 
Categories of the component Environmental Factors: 
 
ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
 
 e110   
Products or substances for 
personal consumption 
 e115   
Products and technology for 
personal use in daily living 
 e310   Immediate family 
 e315   Extended family 
 e320   Friends 
 e325   
Acquaintances, peers, 
colleagues, neighbours and 
community members 
 e330   People in positions of authority 
 e340   
Personal care providers and 
personal assistants 
 e355   Health professionals 
 e360   Other professionals 
 e410   
Individual attitudes of immediate 
family members 
 e415   
Individual attitudes of extended 
family members 
 e420   Individual attitudes of friends 
 e425   
Individual attitudes of 
acquaintances, peers, 
colleagues, neighbours and 
community members 
 e430   
Individual attitudes of people in 
positions of authority 
 e440   
Individual attitudes of personal 
care providers and personal 
assistants 
 e450   
Individual attitudes of health 
professionals 
 e455   
Individual attitudes of other 
professionals  
 e465   
Social norms, practices and 
ideologies 
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ICF Code ICF Category 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
 
 e510   
Services for the production of 
consumer goods 
 e550   
Legal services, systems and 
policies 
 e555   
Associations and organizational 
services, systems and policies 
 e560   
Media services, systems and 
policies 
 e570   
Social security services, systems 
and policies 
 e575   
General social support services, 
systems and policies 
 e580   
Health services, systems and 
policies 
 e585   
Education and training services, 
systems and policies 
 e590   
Labour and employment 
services, systems and policies 
 e595   
Political services, systems and 
policies 
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10.2  Questionnaire of the First Delphi Round 
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10.3  Questionnaire of the Second Delphi Round (first page) 
 
 
Delphi Exercise Round 2  Physicians
ICF code ICF category title ICF category description YES/NO
b1100 State of consciousness Mental functions that when altered produce states such 
as clouding of consciousness, stupor or coma. 
b1301 Motivation Mental functions that produce the incentive to act; the 
conscious or unconscious driving force for action. 
b1303 Craving Mental functions that produce the urge to consume 
substances, including substances that can be abused. 
b134 Sleep functions General mental functions of periodic, reversible and 
selective physical and mental disengagement from one’s 
immediate environment accompanied by characteristic 
physiological changes. 
b152 Emotional functions Specific mental functions related to the feeling and 
affective components of the processes of the mind. 
b1522 Range of emotion Mental functions that produce the spectrum of 
experience of arousal of affect or feelings such as love, 
hate, anxiousness, sorrow, joy, fear and anger.
ICF code ICF category title ICF category description YES/NO
b210 Seeing functions Sensory functions relating to sensing the presence of 
light and sensing the form, size, shape and colour of the 
visual stimuli. 
b2100 Visual acuity functions Seeing functions of sensing form and contour, both 
binocular and monocular, for both distant and near 
vision. 
b2102 Quality of vision Seeing functions involving light sensitivity, colour vision, 
contrast sensitivity and the overall quality of the picture. 
b21023 Visual picture quality Seeing functions involving the quality of the picture. 
b230 Hearing functions Sensory functions relating to sensing the presence of 
sounds and discriminating the location, pitch, loudness 
and quality of sounds. 
Do you agree that this ICF category represents patients' 
problems, patients' resources or aspects of the 
environment treated by physicians in patients with diabetes 
mellitus ?
Do you agree that this ICF category represents patients' 
problems, patients' resources or aspects of the 
environment treated by physicians in patients with diabetes 
mellitus ?
91 
 
10.4  Questionnaire of the Third Delphi Round (first page) 
 
 
 
 
 
 
 
 
 
 
 
Delphi Exercise Round 3  Physicians
ICF code ICF category title ICF category description ID-number % 
agreement
YES/NO
b1100 State of consciousness Mental functions that when altered produce states such 
as clouding of consciousness, stupor or coma. 
1;2;3;4;5;6;7;8;9;10;11;12;13;14
;16;17;18;19;20;21;23;24;25;26;
27;28;29;30;31;32;33;34;35;36; 
37;38;40;41;42;43;44;45;46;47; 
48;49;50;51;52;53;54;55;56;57; 
58;59;60;61;62;63;65;66;68;70; 
72;73;74;75;76;77;78
89.9%
b1301 Motivation Mental functions that produce the incentive to act; the 
conscious or unconscious driving force for action. 
1;3;5;7;9;12;14;17;18;19;20;21;
22;24;25;26;27;28;29;30;31;32; 
33;34;35;36;37;38;39;40;42;43; 
44;45;46;47;48;49;50;51;52;53; 
54;55;56;57;58;60;61;62;63;64; 
65;67;68;69;70;72;74;75;76;77; 
78
79,9%
b1303 Craving Mental functions that produce the urge to consume 
substances, including substances that can be abused. 
3;4;5;7;9;10;12;14;17;18;20;23;
24;25;26;28;29;31;32;33;34;35; 
36;37;38;39;43;44;45;46;47;48; 
49;50;51;52;53;54;55;56;57;58; 
61;63;64;67;68;70;72;73;74;75; 
76; 77;78
69,6%
b134 Sleep functions General mental functions of periodic, reversible and 
selective physical and mental disengagement from one’s 
immediate environment accompanied by characteristic 
physiological changes. 
2;3;4;5;6;7;9;12;16;17;19;23;25;
26;28;29;30;31;32;33;34;35;36; 
37;38;40;42;43;44;45;46;47;48; 
49;50;51;52;53;54;55;56;57;58; 
59;61;62;63;64;66;68;69;70;72; 
73;74;75;76;77;78
74,7%
b152 Emotional functions Specific mental functions related to the feeling and 
affective components of the processes of the mind. 
1;2;3;4;5;7;8;9;12;13;14;17;19; 
21;22;24;25;26;27;29;30;31;32; 
33;34;35;36;37;38;39;40;43;44; 
45;46;47;48;49;50;51;52;53;54; 
55;56;57;58;59;60;61;62;63;64; 
65;67;68;69;70;72;73;75;76;77; 
78;79
82,3%
b1522 Range of emotion Mental functions that produce the spectrum of 
experience of arousal of affect or feelings such as love, 
hate, anxiousness, sorrow, joy, fear and anger.
1;2;3;4;5;8;9;14;17;19;20;21;24;
25;26;27;29;30;31;32;33;34;35; 
37;38;39;42;43;44;45;46;47;48; 
49;50;51;52;53;54;55;56;57;58; 
60;61;62;63;64;67;68;69;70;72; 
73;75;76;77;78;79
100,0%
Taking into account the answer of the group and your individual answer in the second 
round, do you agree that this ICF category represents patients' problems, patients' 
resources or aspects of the environment treated by physicians in patients with diabetes 
mellitus?
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10.5  Results from the second and third Delphi Round 
 
 
Body Functions: 
 
ICF Code ICF category title 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
   
 
 
b110   Consciousness functions   
  b1100  State of consciousness 89.9 98.7 
 b130   Energy and drive functions   
  b1300  Energy level   
  b1301  Motivation 79.7 86.8 
  b1302  Appetite   
  b1303  Craving 69.6 68.4 
 b134   Sleep functions 74.7 82.9 
 b140   Attention functions   
 b152   Emotional functions 82.3 88.0 
  b1522  Range of emotion 100 88.2 
 b210   Seeing functions 79.7 86.7 
  b2100  Visual acuity functions 93.7 97.4 
  b2102  Quality of vision 86.1 94.7 
   b21023 Visual picture quality 80.8 85.1 
 b230   Hearing functions 62.0 62.7 
  b2401  Dizziness 89.9 92.0 
 b260   Proprioceptive function   
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ICF Code ICF category title 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
   
 b265   Touch function 94.9 97.3 
 b270   
Sensory functions related to 
temperature and other stimuli 
97.5 98.7 
  b2702  Sensitivity to pressure 88.6 94.7 
  b2703  Sensitivity to a noxious stimulus 94.8 98.7 
 b280   Sensation of pain 97.5 97.3 
   b28011 Pain in chest 89.7 92.0 
   b28014 Pain in upper limb 83.5 88.0 
   b28015 Pain in lower limb 98.7 100 
   b28016 Pain in joints 75.9 73.3 
 b410   Heart functions 89.7 94.7 
  b4101  Heart rhythm 83.5 85.3 
  b4103  Blood supply to the heart 88.5 93.3 
 b415   Blood vessel functions 91.1 97.3 
  b4150  Functions of arteries 98.7 100 
  b4151  Functions of capillaries 87.3 93.1 
  b4152  Functions of veins 69.9 68.0 
 b420   Blood pressure functions 94.9 96.0 
  b4200  Increased blood pressure 97.5 98.7 
  b4201  Decreased blood pressure 84.8 88.0 
  b4202  Maintenance of blood pressure 94.9 98.7 
 b430   
Haematological system 
functions 
73.4 77.3 
  b4300  Production of blood 59.5 58.1 
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ICF Code ICF category title 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
   
  b4302  
Metabolite-carrying functions of 
the blood 
67.1 64.0 
  b4303  Clotting functions 72.2 73.3 
 b435   
Immunological system 
functions 
91.1 94.7 
  b4350  Immune response 88.6 94.7 
 b440   Respiration functions 67.1 66.7 
 b455   Exercise tolerance functions   
  b4550  General physical endurance 84.8 92.0 
  b4551  Aerobic capacity   
  b4552  Fatiguability 88.6 90.5 
  b5104  Salivation 59.5 65.3 
  b5105  Swallowing 65.8 68.9 
  b5106  Regurgitation and vomiting 83.5 82.7 
 b515   Digestive functions 86.1 90.7 
  b5150  
Transport of food through 
stomach and intestines 
91.0 94.7 
  b5151  Breakdown of food 60.8 60.0 
  b5153  Tolerance to food 62.0 57.3 
 b525   Defecation functions 83.5 89.3 
  b5251  Faecal consistency 79.7 76.0 
  b5252  Frequency of defecation 83.5 85.3 
  b5253  Faecal continence 74.7 77.0 
 b530   Weight maintenance functions 93.7 93.3 
 b535   
Sensations associated with the 
digestive system 
75.9 81.3 
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ICF Code ICF category title 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
   
  b5350  Sensation of nausea 79.7 82.7 
 b540   General metabolic functions 93.7 98.7 
  b5401  Carbohydrate metabolism 92.4 97.3 
  b5403  Fat metabolism 91.1 95.9 
 b545   
Water, mineral and electrolyte 
balance functions 
97.3 93.3 
  b5450  Water balance 80.8 86.7 
  b5451  Mineral balance 75.9 81.1 
 b555   Endocrine gland functions 91.1 95.9 
 b610   Urinary excretory functions 87.3 92.0 
  b6100  Filtration of urine 87.2 96.0 
 b620   Urination functions 92.4 96.0 
  b6201  Frequency of urination 93.6 97.3 
  b6202  Urinary continence 83.5 90.7 
 b630   
Sensations associated with 
urinary functions 
  
 b640   Sexual functions 98.7 97.3 
  b6400  
Functions of sexual arousal 
phase 
78.2 78.7 
  b6401  
Functions of sexual preparatory 
phase 
82.1 86.5 
 b650   Menstruation functions 74.7 77.0 
 b660   Procreation functions   
  b6600  Functions related to fertility 73.4 72.6 
  b6601  Functions related to pregnancy 89.9 94.7 
  b6602  Functions related to childbirth 84.8 89.3 
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ICF Code ICF category title 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th 
level 
   
  b6700  
Discomfort associated with 
sexual intercourse 
79.7 84.0 
 b710   Mobility of joint functions 73.4 73.3 
  b7100  Mobility of a single joint 72.2 73.3 
  b7102  Mobility of joints generalized 69.6 62.7 
  b7200  Mobility of scapula 50.6 48.0 
 b730   Muscle power functions 69.6 66.7 
 b740   Muscle endurance functions 65.8 65.3 
 b770   Gait pattern functions 73.4 72.0 
  b7800  Sensation of muscle stiffness 67.1 64.0 
  b7801  Sensation of muscle spasm 65.8 58.7 
 b810   
Protective functions of the 
skin 
84.8 88.0 
 b820   Repair functions of the skin 87.3 93.3 
 b830   Other functions of the skin 79.7 81.3 
 b840   Sensation related to the skin 92.2 96.0 
 b850   Functions of hair 48.1 40.0 
 b860   Functions of nails 68.4 70.7 
 
 
 
 
 
 
 
 
 
 
97 
 
Body Structures: 
 
ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
 s140   
Structure of sympathetic 
nervous system 
82.3 89.3 
 s150   
Structure of 
parasympathetic nervous 
system 
78.5 88.0 
 s220   Structure of eyeball 64.6 69.9 
  s2203  Retina 94.9 97.3 
  s2204  Lens of eyeball 93.7 98.7 
 s320   Structure of mouth 60.8 64.4 
  s3200  Teeth 88.6 94.7 
  s3301  Oral pharynx 74.7 76.0 
 s410   
Structure of cardiovascular 
system 
91.1 94.7 
  s4100  Heart 98.7 98.7 
  s4101  Arteries 98.7 98.7 
  s4102  Veins 78.5 85.3 
  s4103  Capillaries 84.8 93.3 
 s430   
Structure of respiratory 
system 
73.4 77.3 
 s530   Structure of stomach 65.8 67.6 
  s5400  Small intestine 73.4 80.0 
  s5401  Large intestine 75.9 80.0 
 s550   Structure of pancreas 77.2 84.0 
 s560   Structure of liver 78.5 86.7 
  s5801  Thyroid gland 79.7 89.3 
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ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
 s610   Structure of urinary system 78.5 88.0 
  s6100  Kidneys 98.7 97.3 
  s6102  Urinary bladder 89.9 94.7 
 s630   
Structure of reproductive 
system 
  
   s63033 Vaginal canal 73.4 78.4 
  s6306  Prostate 63.3 65.3 
 s720   Structure of shoulder region 55.1 58.1 
  s7201  Joints of shoulder region 62.8 62.7 
 s730   Structure of upper extremity 59.0 58.1 
  s7302  Structure of hand 74.4 71.6 
   s73021 Joints of hand and fingers 79.5 77.3 
 s750   Structure of lower extremity 79.5 80.0 
  s7500  Structure of thigh 59.0 68.0 
  s7501  Structure of lower leg 76.9 82.7 
  s7502  Structure of ankle and foot 93.6 96.0 
  s7700  Bones 75.6 82.7 
  s7701  Joints 75.6 80.0 
  s7702  Muscles 82.1 86.7 
 s810   Structure of areas of skin 82.1 92.0 
  s8102  Skin of upper extremity 70.5 77.3 
  s8104  Skin of lower extremity 94.9 96.0 
 s830   Structure of nails 88.5 91.8 
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Activities and Participation: 
 
 
ICF Code 
 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
  d1551  Acquiring complex skills 51.9 50.7 
 d230   Carrying out daily routine 59.9 56.0 
  d2301  Managing daily routine 60.8 56.0 
  d2302  Completing the daily routine 65.8 60.0 
 d240   
Handling stress and other 
psychological demands 
  
 d440   Fine hand use 60.8 59.5 
 d450   Walking   
 d455   Moving around   
 d475   Driving 56.4 58.7 
  d4751  Driving motorized vehicles 52.6 53.3 
 d520   Caring for body parts   
 d570   Looking after one’s health 81.0 85.1 
  d5701  Managing diet and fitness 92.3 91.8 
  d5702  Maintaining one's health 85.9 88.0 
 d620   
Acquisition of goods and 
services 
46.8 41.3 
 d630   Preparing meals   
  d6505  
Taking care of plants, indoors 
and outdoors 
32.9 23.7 
 d660   Assisting others 48.1 36.8 
 d750   Informal social relationships 48.1 39.5 
 d760   Family relationships 59.5 59.2 
 d770   Intimate relationships 62.0 68.4 
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ICF Code 
 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
 d820   School education 58.2 56.0 
 d840   
Apprenticeship (work 
preparation) 
51.9 44.7 
 d845   
Acquiring, keeping and 
terminating a job 
60.8 61.8 
  d8450  Seeking employment 51.9 48.7 
 d850   Remunerative employment 52.6 48.0 
 d855   non-remunerative employment 41.8 28.9 
  d8700  Personal economic resources 49.4 42.1 
 d910   Community life 46.8 40.8 
  d9100  Informal associations 48.1 40.8 
  d9101  Formal associations 42.3 35.5 
 d920   Recreation and leisure 64.6 67.1 
  d9201  Sports 73.4 77.6 
  d9204  Hobbies   
  d9205  Socializing   
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Environmental Factors: 
 
ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
 e110   
Products or substances for 
personal consumption 
  
  e1100  Food 84.8 90.8 
  e1101  Drugs 86.1 90.8 
 e115   
Products and technology for 
personal use in daily living 
58.2 55.3 
  e1150  
General products and 
technology for personal use in 
daily living 
55.7 49.3 
  e1151  
Assistive products and 
technology for personal use in 
daily living 
68.4 68.9 
 e120   
Products and technology for 
personal indoor and outdoor 
mobility and transportation 
56.4 56.0 
  e1250  
General products and 
technology for communication 
54.4 50.7 
 e130   
Products and technology for 
education 
53.2 48.7 
  e1300  
General products and 
technology for education 
59.0 51.3 
  e1650  Financial assets 38.0 30.3 
  e2151  Population density 30.4 30.3 
  e2250  Temperature 51.9 46.1 
  e2255  Seasonal variation 50.6 47.4 
 e230   natural events 48.1 38.2 
 e310   Immediate family 67.1 69.7 
 e315   Extended family 53.2 53.9 
 e320   Friends   
 e325   
Acquaintances, peers, 
colleagues, neighbours and 
community members 
57.0 53.9 
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ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
 e330   
People in positions of 
authority 
55.7 52.6 
 e335   People in subordinate positions 49.4 36.8 
 e340   
Personal care providers and 
personal assistants 
63.3 64.0 
 e355   Health professionals 84.8 89.3 
 e360   Other professionals 53.2 51.3 
 e410   
Individual attitudes of 
immediate family members 
71.8 71.1 
 e415   
Individual attitudes of 
extended family members 
56.4 55.3 
 e420   
Individual attitudes of 
friends 
60.3 63.2 
 e425   
Individual attitudes of 
acquaintances, peers, 
colleagues, neighbours and 
community members 
60.8 59.2 
 e430   
Individual attitudes of people 
in positions of authority 
  
 e440   
Individual attitudes of 
personal care providers and 
personal assistants 
  
 e450   
Individual attitudes of health 
professionals 
69.6 73.7 
 e455   
Individual attitudes of other 
professionals  
  
 e460   Societal attitudes 62.0 64.5 
 e465   
Social norms, practices and 
ideologies 
59.5 60.5 
 e510   
Services for the production 
of consumer goods 
  
 e530   
Utilities services, systems and 
policies 
49.4 32.0 
  e5350  Communication services 49.4 40.0 
 e540   
Transportation services, 
systems and policies 
48.1 33.3 
  e5401  Transportation systems 51.9 58.7 
 e550   
Legal services, systems and 
policies 
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ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
  e5500  Legal services 40.5 32.0 
 e555   
Associations and 
organizational services, 
systems and policies 
49.4 40.0 
  e5550  
Associations and 
organizational services 
51.9 49.3 
  e5552  
Associations and 
organizational policies 
52.6 49.3 
 e560   
Media services, systems and 
policies 
51.9 48.0 
  e5600  Media services 58.2 64.0 
 e565   
Economic services, systems 
and policies 
44.3 38.7 
  e5650  Economic services 45.6 40.0 
 e570   
Social security services, 
systems and policies 
62.0 61.3 
  e5700  Social security services 68.4 71.6 
  e5701  Social security systems 64.5 61.6 
 e575   
General social support 
services, systems and 
policies 
66.2 65.3 
  e5750  
General social support 
services 
68.4 67.6 
 e580   
Health services, systems 
and policies 
81.0 92.0 
  e5800  Health services 87.3 94.6 
  e5801  Health systems 82.9 88.9 
  e5802  Health policies 76.0 85.1 
 e585   
Education and training 
services, systems and 
policies 
65.4 68.5 
 e590   
Labour and employment 
services, systems and 
policies 
  
  e5900  
Labour and employment 
services 
57.0 50.0 
 e595   
Political services, systems 
and policies 
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ICF Code 
 
ICF category title 
 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
1st 
level 
2nd 
level 
3rd 
level 
4th  
Level 
   
  e5951  Political systems 43.6 39.2 
 
 
Personal Factors: 
 
Answer 
 
Personal factors 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
Comorbidities 100 98.7 
Compliance 94.9 98.7 
Conviction 70.9 82.7 
Coping 88.6 93.3 
Health literacy 83.5 93.3 
Healthy lifestyle 97.5 98.7 
Heritability of diabetes 88.6 92.0 
Knowledge about disease 98.7 98.7 
Lack of self-confidence 89.9 97.3 
Patient education about disease 100 98.7 
Self empowerment 89.9 93.3 
Self management 97.5 98.7 
Self-decision making 89.9 94.7 
Understanding of therapeutic strategies 98.7 98.7 
Loss of liberty 81.0 86.7 
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Health conditions: 
 
Answer 
 
Health conditions 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
Abscess 
92.4 98.6 
Anaemia 
84.4 91.9 
Arthritis 
78.5 80.0 
Cardiovascular diseases 
100 100 
Carpal tunnel syndrome 
89.9 94.7 
Cataract 
94.9 97.3 
Cerebrovascular disease 
98.7 100 
Coeliac disease 
75.9 80,0 
Depression 
97.5 100 
Diabetes neuropathy 
100 100 
Diabetic foot 
98.7 100 
Diverticulitis 
59.5 53.3 
Endocrine disorders 
94.9 98.7 
Gestational diabetes 
96.2 98.7 
Gout 
83.5 87.8 
Intercurrent pneumonia 
84.8 93.3 
Nephropathy 
100 100 
Obesity 
100 100 
Osteomyelitis 
88.6 93.3 
Osteoporosis 
84.8 88.0 
Peripheral vascular disease 
100 100 
Pregnancy 
88.6 94.7 
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Answer 
 
Health conditions 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
Pulmonary TBC infection 
81.0 82.7 
Renal hypertension 
88.6 93.3 
Retinopathy 
98.7 97.3 
Scleroedema of skin 
64.6 66.7 
Sepsis 
91.1 97.3 
Sleep apnea 
84.8 89.3 
Type 1 Diabetes 
96.2 100 
Type 2 Diabetes 
97.5 100 
 
 
Not classified: 
 
Answer 
 
Not classified 
round 2 
n= 79 
% 
round 3 
n= 76 
% 
Aggravation of diabetes 91.1 97.3 
Antibiotic resistance 75.9 78.4 
Dealing with the complex medicines and eating dosage regimen 94.9 98.6 
Diabetic research 88.6 93.2 
Exercise opportunity 89.9 95.9 
Insulin resistance 93.7 97.3 
Lack of communication between patient and physician 97.5 97.3 
neuropathy problems 100 100 
Patients are always on the lookout for the proverbial 'cure' 83.5 97.8 
Screening for relatives 91.1 93.2 
Swelling in their joints 66.7 70.3 
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10.6  ICF Definitions  
 
 
(Extracted from WHO, 2001) 
 
Body Functions are the physiological functions of the body systems 
(including psychological functions). 
 
Body Structures are the anatomical parts of the body such as organs, limbs 
and their components. 
 
Impairment is a loss or abnormality in body structure or physiological function 
(including mental functions). 
 
Activity is the execution of a task or action by an individual. 
 
Participation is involvement in a life situation. 
 
Activity limitations are difficulties an individual may have in executing 
activities. 
 
Participation restrictions are problems an individual may experience in 
involvement in life situations. 
 
Environmental Factors make up the physical, social and attitudinal 
environment in which people live and conduct their lives. 
 
 
 
 
 
 
 
 
108 
 
10.7  Abbreviations 
 
ADA  American Diabetes Association 
BMD  Bone mineral density 
CVD  Cardiovascular disease 
CAN  Cardiovascular autonomic neuropathy 
CTS  Carpal tunnel syndrome 
DSME  Diabetes self-management education 
DIMDI  Deutsches Institut für Medizinische Dokumentation und  
   Information 
DAN  Diabetic autonomic neuropathy 
DPN  Diabetic distal sensory polyneuropathy 
DKA  Diabetic ketoacidosis 
DD   Dupuytren’s disease 
DM   Diabetes mellitus 
ESRD  End-stage renal disease 
GDM  Gestational diabetes mellitus 
GN   Glycogenic hepatopathy 
HHS  Hyperosmolar hyperglycaemic state 
ICD  International Classification of Diseases 
ICF   International Classification of Functioning, Disability and Health 
ICIDH  International Classification of Impairments, Disability and  
Handicaps 
IDF  International Diabetes Federation 
IGT  Impaired glucose tolerance 
IFG  Impaired fasting glucose 
LJM  Limited joint mobility 
MODY  Maturity-onset-diabetes of the young 
MNT  Medical nutrition therapy 
NAFLD  Non-Alcoholic Fatty Liver disease 
NASH  Non-Alcoholic Steatohepatitis 
PCOS  Polycystic ovary syndrome 
SMBG  Self monitoring of blood glucose 
WHO   World Health Organization 
